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In this Thesis we have analyzed, using Drosophila as a model system, the function of dRYBP 
(drsosophila Ring and YY1 binding protein) in the control of gene expression. The genetic and 
biochemical analysis of dRYBP reveals its role in the epigenetic control of gene expression and 
in the regulation of cell death. dRYBP controls these processes by two different mechanisms: 
one, a transcription-dependent mechanism whereby dRYBP, together with the Polycomb and 
trithorax proteins, modulates levels of post-translationally modified histones. The second one, a 
transcription-independent mechanism whereby dRYBP regulates the apoptotic pathway through 
its interaction with the SCF E3 ubiquitin ligase complex, involved in proteasomal degradation 
of target proteins. The conclusions of this Thesis are: 1) The dRYBP protein coexists, in 
Drosophila S2 cells, in two different forms: the dRYBP and the monoubiquitylated dRYBP 
(dRYBPub) proteins. Moreover, the dRYBP protein binds to ubiquitylated proteins through its 
N-terminal, where the NZF domain is located. 2) The dRYBP protein interacts with the H2A, 
H2B, H2Aub and H2Bub histones in Drosophila S2 cells. Additionally, dRYBP genetically 
interacts with Sce/dRing, dkdm2 and dBre1 and biochemically, in Drosophila wild type 
embryonic nuclear protein extracts (dNE), with SCE/dRING, dKDM2 and dBRE1. 3) The 
dRYBP protein does not biochemically interact with the PSC, PC, PH and EZ proteins and 
dBRE1 does not interact with the SCE/dRING, dKDM2 and EZ proteins in dNE. 4) Inactivation 
of dRYBP decreases levels of monoubiquitylated H2A (H2Aub) and monomethylated H3K4 
(H3K4me). 5) dRYBP counteracts dKDM2-mediated H3K36me2	   demethylation and dBRE1-
mediated H2B monoubiqutylation. These dRYBP-mediated activities may therefore attenuate 
dkdm2-mediated repression and dBRE1-mediated activation. 6) The dRYBP gene interacts 
genetically with skpA, dCul1 and slmb, all members of the SCF E3 ubiquitin ligase complex. 
Moreover, the dRYBP protein biochemically interacts with SKPA and dCUL1 proteins. 7) 
Inactivation of dRYBP, skpA, dCul1 and slmb induces apoptosis in the wing imaginal disc and 
the inactivation of skpA- and dRYBP-induced apoptosis is dependent on the expression levels of 
the pro-apoptotic gene rpr and the anti-apoptotic protein DIAP1. Thus the dRYBP-SCF 
complex functions by inhibiting the intrinsic apoptotic pathway. 8) Inactivation of skpA in wing 
imaginal discs and in Drosophila S2 cells, induces the transcriptional activation of rpr and 
diap1, increases Rpr protein levels and decreases DIAP1 protein levels. 9) High levels of SKPA 
rescues the apoptotic wing phenotype induced by overexpression of Rpr. Moreover, in human 
HEK293 cells, SKPA protein biochemically interacts with Rpr and DIAP1 proteins and SKPA 
overexpression decreases Rpr protein levels, suggesting that the dRYBP-SCF complex post-
translationally regulates Rpr protein levels. 10) High levels of SKPA inhibit both the apoptosis 
that occurs during normal leg development and X-ray-induced apoptosis. 
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1. Drosophila melanogaster AS A MODEL SYSTEM  
Developmental biology studies the mechanisms underlying the growth and development 
of a single cell, the fertilized oocyte, to an adult organism. The fruit fly Drosophila 
melanogaster is one of the most relevant model systems used to analyze the mechanisms 
controlling the genetic regulation of cell proliferation, differentiation and morphogenesis. 
This is due to numerous advantages among which we find it is small size and easy to grow, it 
has a short life cycle, it has a high fecundity and only four chromosomes compose the whole 
genome. Moreover, the Drosophila genome is phylogenetically conserved. The identity at the 
nucleotide level between Drosophila and humans is approximately 40%, however the 
conservation in functional domains can approximately be 80% to 90% or higher (Pandey and 
Nichols, 2011). Interestingly 75% of human disease genes have a homolog in Drosophila 
(Reiter et al., 2001) and importantly the signaling pathways controlling development are also 
evolutionary conserved (Vidal and Cagan, 2006). Additionally, the use of Drosophila as a 
model system for studying developmental biology has allowed the generation of genetic 
tools, such as a library of transgenic flies that allows gene overexpression and inactivation, 
that are not available for other model organisms confirming once more, the advantages of 
Drosophila as a model system. 
The life cycle of Drosophila melanogaster takes place in ten days approximately at 25ºC 
and goes through different developmental stages (Figure 1A).  
 
 
The first stage is the embryonic phase, which lasts approximately twenty-four hours. 
Then, after hatching the resulting larvae grow for about four days while molting twice (to 2nd 
and to 3rd instar larvae). During the larval phase proliferation of the imaginal discs, the 
 
Figure 1. Development of Drosophila melanogaster. (A) Life cycle of Drosophila melanogaster  (B) Larva 
showing salivary glands and imaginal discs and the structure they will give rise to after metamorphosis in the 
adult fly. (Modified from Flymove). 
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primordia of the structures of the adult body, takes place (Figure 1B). The last period of the 
life cycle that also lasts approximately four days, corresponds to the pupal stage, where 
metamorphosis takes place and the abdominal histoblasts proliferate to generate the adult 
abdomen. During metamorphosis many larval tissues are reabsorbed and the imaginal discs 
undergo morphogenetic changes to form adult structures, for example the wing imaginal 
discs will generate the adult wing, the hinge and the thorax (Figure 1B). Afterwards the adult 
fly emerges (Ashburner, 1989). 
 
1.1. Genetic control of Drosophila morphogenesis  
The body of Drosophila, as many other 
insects and organisms is segmented. 
Segmentation occurs very early in 
development and is controlled by a genetic 
cascade that includes many transcription 
factors that function sequentially during 
embryonic development (Figure 2). First, the 
anterior-posterior (A/P) axis is established by 
the maternal genes, such as bicoid and nanos, 
which provide the positional information 
(Lawrence, 1992). The maternal genes, in 
turn, control the expression of the gap genes, 
such as Kruppel, that are expressed in broad 
domains along the A/P axis and, in turn, 
control the expression of the pair rule genes 
(Lawrence, 1992) (Figure 2).  
The pair rule genes are differentially expressed in seven alternative stripes that will 
allocate cells to the prospective 14 parasegments (PS). The parasegments are the metameric 
functional units and are formed by the posterior compartment of one segment and the anterior 
compartment of the following segment (Martinez-Arias and Lawrence, 1985). For example 
the PS6 is composed of the posterior compartment of the T3 segment and the anterior 
compartment of the A1 segment (Figure 3). Once the number of parasegments has been 
established, the segment polarity genes, such as engrailed and wingless, specify the anterior 
and posterior compartments within each parasegment (Lawrence, 1992) (Figure 2). The pair 
rule genes as well as the segment polarity genes regulate the expression of the homeotic 
(Hox) genes, which are responsible for the cellular identity of each segment throughout 
 
Figure 2. Segmentation of the Drosophila 
melanogaster embryo. The maternal proteins 
activate the differential expression pattern of the 
gap genes, which activate the expression of the 
pair rule genes, which activate the expression of 
the segment polarity genes and coordinately 
activate the expression of the homeotic genes. See 
text for more detailed explanations.  
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development (Lawrence, 1992) (Figure 3). Moreover, the homeotic genes specify the 
segmental identity of the cephalic, thoracic and abdominal segments and will ultimately, be 
responsible for the identity of the adult structures and body pattern of the fly (Lewis, 1978).  
The Hox genes codify for 
transcription factors, evolutionary 
conserved, that regulate the expression 
of other genes organizing the 
development of the mesoderm, 
endoderm and ectoderm, the nervous 
system and the epidermis of many 
animals, from fruit flies to vertebrates 
(Akam et al., 1994; Krumlauf, 1994). 
The Hox genes are clustered in the 
Antennapedia (Ant-C) and Bithorax 
complexes (BX-C) (Figure 3). For 
instance, the Scr (Sex combs reduced) 
gene belongs to the Ant-C (Duncan, 
1987; Kaufman et al., 1990) and the 
BX-C is composed of the Ubx 
(Ultrabithorax), abd-A (abdominal A) 
and Abd-B (Abdominal B) genes (first 
described in (Sanchez-Herrero et al., 
1985a)) (Figure 3). As pointed out above, the expression domains of the Hox genes are 
established along the A/P axis very early during embryonic development. These domains 
define the cells where the Hox genes are expressed, “expression domains” and importantly, 
they also define the cells where the Hox genes are repressed, “repression domains” to allow 
normal development (Lawrence, 1992). For instance, the expression of the Ubx gene in the 
3rd dorsal thoracic segment promotes the development of a haltere, while the 2nd dorsal 
thoracic segment, where Ubx is repressed, develops into a wing (Sanchez-Herrero et al., 
1985b). 
Both the “expression” and “repression” domains have to be maintained throughout 
development because alterations, at any time of development in the expression pattern of the 
Hox genes can lead to lethality in most cases, or severe phenotypic transformations. 
Importantly these expression domains of the Hox genes are established by the segmentation 
genes (the gap and the pair rule genes), which are expressed only during the first four hours 
of development (Jackle et al., 1992), while the Hox genes are expressed and required 
 
Figure 3. Homeotic genes. Simplified representation of the 
proximal-distal localization of the Hox genes in the 
chromosome and their expression domains throughout the 
anterior-posterior axis of the Drosophila embryo and adult 
body. In addition the segments, compartments and 
parasegements of the embryo are indicated. See text for 
more detailed explanations.  
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throughout development. Thus, the maintenance of the expression domains of the homeotic 
genes is achieved by another set of genes: the Polycomb (PcG) and trithorax (trxG) groups of 
genes, in charge of maintaining throughout development the repressed and activated 
transcriptional states of the Hox genes respectively (Kennison and Tamkun, 1988; Lewis, 
1978; Simon et al., 1992).  
The PcG and trxG are nuclear proteins that are ubiquitously expressed throughout 
development. Initially discovered in Drosophila as regulators of the Hox genes, it is now 
known that they are evolutionary conserved and that they regulate the expression of many 
other genes involved in diverse biological processes such as proliferation, stem cell 
pluripotency and tumorigenesis (Ferres-Marco et al., 2006; Martinez et al., 2006; Oktaba et 
al., 2008; Probst et al., 2009). There are at least 40 genes that have been described as PcG 
and trxG genes. These genes codify for proteins with different domains that function in 
multiprotein complexes composed of either PcG or trxG proteins. These complexes modulate 
chromatin condensation by post-translationally modifying histones leading to transcriptional 
repression in the case of PcG proteins or transcriptional activation in the case of trxG proteins 
(Schuettengruber and Cavalli, 2010; Schwartz and Pirrotta, 2007). Additionally, within the 
described PcG and trxG, there is a set of genes that codify for proteins that interact with both 
PcG and trxG proteins and are known as ETPs (Enhancers of Trithorax and Polycomb) 
(Bejarano and Busturia, 2004; Busturia et al., 2001; Gildea et al., 2000). Among the ETPs we 
find the dRYBP (drosophila Ring1B Yin yang1 binding protein) protein (Bejarano et al., 
2005; Gonzalez et al., 2008), object of study of this thesis work and which will be described 
in more detail in section 3.2. of the introduction. 
 
2. REGULATION OF GENE EXPRESSION  
All organisms seek for homeostasis to reach a correct development and maintain a healthy 
life. This is accomplished through an active response to external and internal signals that 
ultimately allow organisms to survive against harmful attacks. A miss-regulation of gene 
expression during both development and the adult life can lead to diseases such as cancer or 
neurodegenerative disorders (Bray et al., 2005; Ferres-Marco et al., 2006). Hence an accurate 
regulation of gene expression is crucial during development to achieve correct 
morphogenesis. 
Regulation of gene expression occurs at different stages underlying different molecular 
mechanisms at the level of chromatin, DNA, RNA, translation and also at the post-
translational level. For example, chromatin condensation, which can be altered as a result of 
histone post-translational modifications, results in a transcriptional activation or repression of 
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gene expression (Hubner et al., 2013). Also, DNA transcription can be regulated by different 
mechanisms. One of them is mediated by transcription factors that control the temporal and 
spatial regulation of gene expression by physically binding to cis-regulatory enhancers or 
silencers present at the DNA targets, altering the specificity of the RNA polymerase for a 
given promoter (Gaarenstroom and Hill, 2014). Moreover, post-transcriptional regulation 
includes mRNA modifications, including alternative splicing, addition of the poly(A) tail (Xu 
et al., 1994), or regulation by micro-RNAs (Ambros, 2004). Translation can also be regulated 
by the secondary structure of the mRNA or protein binding (Cheadle et al., 2005). 
Furthermore, proteins can be post-translationally modified by the attachment of one or 
several biochemical groups, such as ubiquitin, modifying the nature and/or structure of the 
target protein (Mann and Jensen, 2003). Consequently post-translational modifications 
change protein activity promoting their degradation, activation, inactivation or changing its 
cellular localization (Inuzuka et al., 2011; Kulathu and Komander, 2012; Mann and Jensen, 
2003; Osley, 2004). Several post-translational modifications regulate protein activity like 
phosphorylation, methylation, sumoylation and protein ubiquitylation, object of study of this 
thesis work.  
 
2.1. Protein ubiquitylation 
Protein ubiquitylation is a post-translational modification that involves a series of catalytic 
reactions resulting in the covalent attachment of one (mono-) or several (poly-) molecules of 
ubiquitin to a lysine residue in the target protein (Ciechanover et al., 1980; Hershko et al., 
1979). Apart from the lysine residues in the target protein, the ubiquitin molecule can be a 
target itself for ubiquitylation. It has seven lysine residues: K6, K11, K27, K29, K33, K48 
and K63, opening the possibility of forming different type of linkages depending on the 
lysine that is used for ubiquitin chain elongation that can affect protein function in many 
different ways, such as endocytosis, proteolysis and trafficking (Kulathu and Komander, 
2012) (Figure 4). Additionally proteins can non-covalently bind to a ubiquitin molecule or 
poly-ubiquitin chain that has been previously attached to a target protein, in order to transmit 
the information conferred in protein ubiquitylation. This occurs through ubiquitin binding 
domains (UBD), which are protein domains structurally diverse that recognize ubiquitylated 
targets (Hicke et al., 2005) (Table 1).  
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Table 1. Ubiquitin binding domains (UBD) 
Domain 
Length 
(aa) 
Ubiquitin-binding affinity (Kd in µM) 
CUE (coupling of ubiquitin conjugation to 
endoplasmic reticulum degradation) 
42-43 2-160µM (binds monoubiquitin) 
GAT (Gga and TOM1) 135 180µM (monoubiquitin) 
GLUE (GRAM-like ubiquitin-binding in Eap45) ~135 460µM (binds monoubiquitin) 
NZF (Nucleoporin Zinc Finger) 35 100-400µM (binds monoubiquitin) 
PAZ (polyubiquitin-associated zinc finger) 58 Not known 
UBA (Ubiquitin-associated domain) 45-55 
10-500µM (binds monoubiquitin) 0.03-
9mM (binds polyubiquitin) 
UEV (ubiquitin-conjugating enzyme variant) ~145 100-500µM (binds monoubiquitin) 
UIM (ubiquitin-interacting motif) ~ 20 
100-400µM (binds mono and 
polyubiquitin) 
VHS (Vps27, HRS, STAM) 150 Not known 
 
The ubiquitylation pathway involves three different steps carried out by three different 
enzymes (Figure 4). The first one is the E1 ubiquitin-activating enzyme that forms, in an 
ATP-dependent manner, a thioester linkage between the ubiquitin and itself. The second step, 
carried out by the E2 ubiquitin-conjugating enzyme, catalyzes the transfer of ubiquitin from 
the E1 to the active-site cysteine of the E2. The third and final step is executed by the E3 
ubiquitin ligase enzyme and results in the formation of an isopeptide bond between the C-
terminal of the ubiquitin and the lysine residue of the target protein (Ciechanover et al., 1982; 
Hershko et al., 1983). The ubiquitylation pathway is evolutionary conserved from fly to 
humans (Bocca et al., 2001; Zhang and Sidhu, 2014). The variety of proteins involved makes 
the process of ubiquitylation very diverse and complex but also very specific in order to 
ensure the attachment of the right number of ubiquitin molecules to the intended substrate in 
the correct position. There exists one gene in Drosophila (uba1), and two functional homolog 
genes in humans that codify for the E1. There are few more genes that codify for the E2 in 
Drosophila and humans and many more that encode for the E3.  
One of the most important superfamilies of E3 ubiquitin ligases is the SCF (SKP1-CUL1-
F-box) (Cardozo and Pagano, 2004). This complex consists of a scaffold protein, Cullin1 
(CUL1), whose C-terminal binds to a RING domain containing protein, and whose N-
terminal binds to the adaptor protein SKP1 (S-Phase associated-Protein 1) that interacts with 
a F-box-containing protein (Jackson and Eldridge, 2002). The F-box-containing protein is the 
subunit responsible for substrate specificity by recruiting the target protein (Bocca et al., 
2001; Skowyra et al., 1997). The SCF complex, originally identified in S. cerevisiae, is 
evolutionarily conserved (Feldman et al., 1997) and has been shown to regulate multiple 
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physiological pathways including those involved in metabolism (Sundqvist et al., 2005) 
apoptosis (Inuzuka et al., 2011; Tan et al., 2006) and genome stability (Silverman et al., 
2012). 
 
 
Figure 4. The ubiquitylation pathway. The coordinate action of the E1 ubiquitin-activating enzyme, the E2 
ubiquitin-conjugating enzyme and the E3 ubiquitin ligase enzyme results in the covalent attachment of one 
(mono) or several (poly) ubiquitin molecules (Ub) to the target protein (substrate). Protein ubiquitylation results in 
different physiological outcomes depending on the number of ubiquitin molecules attached to the substrate and the 
type of linkage. See text for more detailed explanations. 
 
Different types of ubiquitin linkages have different physiological outcomes (Figure 4). For 
instance, monoubiquitylation is involved in epigenetic regulation of gene expression (Tanny 
et al., 2007; Wang et al., 2004) while -K48 type of linkage has been shown to promote 
proteasomal degradation of the targeted protein (Ciechanover et al., 1980), a very relevant 
process to maintain proteins levels, in particular in the process of apoptosis (Bergmann, 2010; 
Vucic et al., 2011). The mechanisms regulating the epigenetic control of gene expression and 
the mechanisms involved in the regulation of the apoptotic signaling pathway will now be 
described.  
 
3. EPIGENETIC REGULATION OF GENE EXPRESSION MEDIATED BY PcG 
AND trxG  
The mechanisms of action of PcG and trxG proteins involve three main steps (Figure 5). 
1) Binding of either PcG and trxG proteins containing specific DNA binding domains, such 
as PHO (Pleiohomeotic) and Trl (Trithorax-like) to specific DNA sequences called 
PRE/TREs (Polycomb and Trithorax Response Elements) found at the target genes. 2) 
Recruitment of PcG and trxG proteins to DNA to form specific multiprotein complexes. 3) 
Histone post-translational modifications, such as methylation, acetylation and ubiquitylation, 
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mediated by the different biochemical activities of each multimeric complex (Figures 5 and 
6), leading to different states of chromatin condensation and hence, different levels of gene 
transcription (Klymenko et al., 2006; Muller and Kassis, 2006; Schuettengruber and Cavalli, 
2010).  
 
 
Figure 5. Mechanism of action of the PcG and trxG proteins. The PcG and trxG proteins are recruited 
to the PREs and TREs (Polycomb/Trithorax Response Elements) in their target genes by their interactions 
with DNA-binding proteins such as PHO and GAF. For gene repression the PRC2 complex, trimethylates 
(Me) H3K27 through E(z). This mark is recognized by the chromodomain of Pc of the PRC1 complex, 
which is then recruited to ubiquitylate (Ub) H2A. The coordinate action of the PRC2 and PRC1 
complexes leads to transcriptional repression of the taget gene. For gene activation the dBRE1 protein 
dBRE1 together with the E2 enzyme Rad6 ubiquitylate (Ub) H2B. This mark recruits other trxG protein 
complexes (Trx) which di- and tri-methylate H3K4, leading to transcriptional activation of target genes. 
 
3.1. PcG and trxG complexes and their biochemical activity  
PcG and trxG proteins (Tables 2 and 3) assemble at PREs into different multimeric 
complexes, each of one with a specific biochemical activity that post-translationally modifies 
histones (Figure 6), which ultimately translates into transcriptional gene repression or 
activation respectively (Muller and Verrijzer, 2009). Some of the best-characterized PcG 
complexes (Table 2), of interest for this thesis work, are the PRC1 (Polycomb Repressive 
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Complex 1) (Shao et al., 1999), the PRC2 (Polycomb Repressive Complex 2) (Czermin et al., 
2002; Muller et al., 2002) and the dRAF (dRing Associated Factors) (Lagarou et al., 2008). 
 
Table 2. Composition of PcG protein complexes  
Complex Drosophila Protein Human  homolog Domain Biochemical activity 
PRC1 Polycomb (PC) CBX2, 4, 6, 7 and 8 Chromodomain Binds H3K27me3 
PRC1 Polyhomeotic (PH) PHC1,2 y 3 Zn finger, SAM  
PRC1/dRAF Posterior sex comb (PSC) 
PCGF1(NSPc1), 
PCGF2(MEL18), 
PCGF4(BMI1) 
Zn finger H2AK119 ubiquityl ligase 
PRC1/dRAF dRING/Sex combs extra (SCE) 
RING1A, RING1B, 
RNF2 RING Zn finger H2AK119 ubiquityl ligase 
PRC1-
associated 
factors 
Sex comb on 
midleg (SCM) SCMH1, SCML2 
Zn finger, SAM, 
MBT Protein recruiter PcG 
PRC2 Enhancer of zeste E(z) EZH1y 2 SET 
H3K9 y H3K27 methyl 
transferase 
PRC2 Extra sex combs (ESC) EED WD40 Cofactor for E(z) 
PRC2 Suppressor of zeste 12 [SU(Z)12] SUZ12 Zn Finger  Cofactor for E(z) 
PRC2-
associated 
factors 
Polycomb-like 
(PCL) 
PCL1(PHF1), 
PCL2(MTF2), 
PCL3(PHF19) 
PHD  
PRC2-
associated 
factors 
Extra sex comb-
like (ESCL) EED 
Repeticiones 
WD40 Cofactor for E(z) 
PRC2-
associated 
factors 
SIR2 SIRT1 Zn finger 
Histone deacetyl 
transferase dependant on 
NAD+ 
dRAF dKDM2 KDM2B, FBXL10 
CXXC Zn 
finger, JmjC, 
Fbox 
H2AK119 ubiquityl ligase, 
H3K36me2 demethyl 
transferase 
PhoRC Pleihomeotic (PHO) YY1 y 2 Zn finger Binds DNA 
PhoRC Pho-like (PHOL) YY1 y 2 Zn finger Binds DNA 
PhoRC 
Scm-related gene 
containing Four 
Mbt domains 
(dSFMBT) 
L3MBTL2, 
MBTD1 MBT, SAM 
Binds H3K9me1, me2 and 
H4K20me1 me2 
PR-DUB Calypso/dBAP1 BAP1 UCH H2AK119 de-ubiquityl transferase 
PR-DUB Additional sex comb (ASX) ASXL1  Cofactor for dBAP1 
 
The core components of the PRC1 complex are the PC (Polycomb), PH (Polyhomeotic), 
PSC (Posterior Sex Comb) and SCE/dRING (Sex Comb Extra) proteins (Shao et al., 1999). 
In addition to these core members, other proteins can associate to PRC1, such as Zeste or 
Scm (Sex comb on midleg), which enhance the repressive activity of the PRC1 (Mulholland 
et al., 2003; Muller and Kassis, 2006)}. The PRC1 is responsible for monoubiquitylating 
histone H2A in K119 (K118 in Drosophila), activity that is mediated by the E3 ubiquitin 
ligase RING domain of the protein SCE/dRING (Buchwald et al., 2006; de Napoles et al., 
2004; Gutierrez et al., 2012; Lagarou et al., 2008) (Figure 6). Additionally, PC has a 
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chromodomain that specifically binds to the trimethylated H3K27 (H3K27me3), a histone 
modification established by PRC2 (Fischle et al., 2003). 
The PRC2 is composed by the EZ (Enhancer of Zeste), ESC (Extra Sex Comb), Su(Z)12 
(Suppresor of Zeste 12) and Nurf55 (Nucleosome remodeling factor 55) proteins. This 
complex is responsible for the trimethylation of the H3K27, the modification that recruits 
PRC1 through its interaction with the chromodomain contained in the PC protein (Czermin et 
al., 2002; Muller et al., 2002) (Figures 5 and 6). This is the “canonical pathway” for 
recruiting PcG proteins but in vertebrates, it has been shown that the PRC1 can also be 
recruited independently from H3K27me3 
(Morey et al., 2013). 
The dRAF complex is composed by 
the proteins SCE/dRING and PSC, both 
members of PRC1, and dKDM2. This 
complex is responsible for two repressive 
biochemical activities due to the presence 
of dKDM2: it demethylates dimethylated 
H3K36 (H3K36me2) and it enhances 
ubiquitylation of H2A (H2Aub) by 
SCE/dRING (Figure 6). This complex is 
considered a “super-repressive” complex 
as it has been shown to ubiquitylate H2A 
more efficiently than PRC1 and removes 
the activating mark H3K36me2 
established by the trxG proteins (Lagarou 
et al., 2008). 
Among the trxG complexes (Table 3) of interest for this thesis work are the dBRE1/Rad6 
complex (Hwang et al., 2003; Robzyk et al., 2000) and the dCOMPASS (Complex of 
proteins associated with Set1) complexes (Mohan et al., 2011). Although the dBRE1/Rad6 
complex has not been described yet as a trxG complex we have included it as a trxG as it 
post-translationally modifies histones to promote transcriptional activation. 
The dBRE1 protein is a RING domain-containing E3 ligase that interacts with the E2 
conjugase enzyme Rad6 to ubiquitylate histone H2B in K123 (H2Bub), a modification 
responsible for transcriptional activation (Nakanishi et al., 2009) (Figures 5 and 6). H2Bub is 
a pre-requisite for the COMPASS complex to modify H3K4 and therefore promote activation 
(Davie and Murphy, 1990; Nakanishi et al., 2009). The COMPASS complex is a “macro-
 
Figure 6. PcG and trxG proteins post-
translationally modify histone tails. Simplified 
representation of the biochemical function of the PcG 
complexes PRC2, PRC1 and dRAF, and the trxG 
complexes BRE1 and COMPASS. PRC2 is 
responsible for trimethylation of H3K27, PRC1 for 
H2AK119 ubiquitylation (K118 in Drosophila) and 
dRAF for H2Aub and for demethylation of 
H3K36me2. BRE1 is responsible for H2BK123 
ubiquitylation, which recruits the COMPASS macro-
complex to di- and trimethylate H3K4. 
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complex” responsible for mono-, di- and trimethylation of H3K4 (Figure 6). In Drosophila 
there are 4 COMPASS complexes: 1) Trithorax (Trx)/COMPASS, 2) Trithorax-related 
(Trr)/COMPASS, 3) dSet1/COMPASS y 4) Ash1/COMPASS (Herz et al., 2013; Mohan et 
al., 2011). The crosstalk between H2Bub and H3K4 di- and trimethylation is still not clear, as 
recent evidence supports it is the interaction between the dBRE1/Rad6 and the dCOMPASS 
complexes through Wdr82 protein what is required for modifying H3K4 rather than the 
ubiquitylation of H2B itself (Thornton et al., 2014). 
 
Table 3. Composition of trxG protein complexes 
Complex Drosophila Protein Human  homolog Domain Biochemical activity 
TAC1/COMPASS Trithorax (TRX) MLL, MLL2, 3 y 5 SET H3K4me3 methyl transferase 
TAC1 dCBP CBP Zn finger, KIX IBiD Acetyl transferase 
TAC1 dUTX UTX JmjC H3K27me3 and me2 demethyl transferase 
TAC1/COMPASS 
Absent, small o 
homeotic discs 1 
(ASH1) 
ASH1L SET H3K4/H3K36 methyl transferase 
TAC1 
Absent, small o 
homeotic discs 2 
(ASH2) 
ASH2L, WRD5 Repeticiones WD40 
Esencial para 
H3K4me3 
SWI-SNF Brama (BRM) BRM, BRG1 
Bromodominio, 
SWI-SNF-like 
helicasa 
Actividad ATPase, 
Binds HAc 
SWI-SNF Moira (MOR) SMARCC2, BAF17A   
SWI-SNF Osa (OSA) ARID1A, BAF250   
SWI-SNF Snf5-related 1 (SNR1) SNF5, ARID4A/B   
COMPASS dSET1 SET1 SET H3K4 methyl transferase 
COMPASS Trithorax-related (TRR)  SET 
H3K4 methyl 
transferase 
dBRE1-RAD6 dBRE1 BRE1 RING Zn finger H2B ubiquityl ligase 
 
3.2. The dRYBP gene and protein 
dRYBP (Ring1B and Yin yang1 Binding Protein) is a Polycomb-dependent transcriptional 
repressor that biochemically and genetically interacts with PcG and trxG proteins thus, it is 
classified as an ETP (Enhancer of Trithorax and Polycomb) (Bejarano et al., 2005; Gonzalez 
et al., 2008). The dRYBP gene is evolutionary conserved and codifies for a nuclear small 
protein of 17kDa ubiquitously expressed throughout development (Figure 7) (Bejarano et al., 
2005). dRYBP contains, in its N-terminal, a Ubiquitin Binding Domain (UBD) of the 
Nucleoporin Zinc Finger (NZF) type (Bejarano et al., 2005), also philogenetically conserved 
and that has been shown to interact with ubiquitin (Alam et al., 2004; Arrigoni et al., 2006) 
(Figure 7). 
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Figure 7. The dRYBP gene and protein. (A) The dRYBP gene structure. The 5’UTR and 3’UTR regions 
(grey), the exons (black) and the intron (line) are indicated. (B) The dRYBP protein structure. The N-
terminal (blue) which contains a NZF motif (green) and the C-terminal (purple) are indicated. Both regions 
are phylogenetically conserved in murine YAF2 (YY1 associated factor) and in murine RYBP (dRYBP 
mammalian homolog). (C) Sequence of the NZFub domain of dRYBP and the homologous genes in the 
indicated species. The Cys responsible for Zn binding (orange), the aminoacids responsible for protein 
folding (blue) and the residues required for ubiquitin binding (green, arrow) are labeled. (D) Wild type 
Drosophila embryo showing dRYBP (green) expression. Note dRYBP is expressed in all cell nuclei. 
 
Loss of dRYBP function produces a range of phenotypes that are highly variable in 
penetrance and expressivity including lethality, female sterility, embryonic mitotic collapse 
and organ size reduction (Gonzalez et al., 2008), suggesting that dRYBP participates in an 
array of biological processes. Furthermore, loss of dRYBP function does not produce 
homeotic phenotypes, but in a sensitized mutant genetic background, for example in an 
heterozygous Sce/dRing mutant or in an heterozygous trx mutant, loss of dRYBP function 
enhances the homeotic phenotypes related to Sce/dRing and trx mutants, confirming once 
again that the dRYBP gene functions as an ETP (Bejarano et al., 2005; Gonzalez et al., 2008). 
Moreover, high levels of dRYBP induce apoptosis (Gonzalez and Busturia, 2009)  and 
interestingly, high levels of human RYBP induce apoptosis only in transformed cells (Novak 
and Phillips, 2008). In addition, both the fly and the vertebrate RYBP interact with a variety 
of apoptosis-related proteins, among them FADD and DREDD, the apoptotic related factors 
containing DD (Death Domain) and DED (Death Effector Domain) (Gonzalez and Busturia, 
2009; Zheng et al., 2001), Apoptin, a viral apoptosis agonist (Danen-van Oorschot et al., 
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2004), Hippi, a pro-apoptotic protein first described in the context of the Huntington’s 
disease (Stanton et al., 2007), and MDM2, an E3 ubiquitin ligase which negatively regulates 
p53 (Chen et al., 2009). In spite of this, the molecular mechanisms controlling 
dRYBP/RYBP-mediated apoptosis are poorly understood.  
 
4. THE APOPTOTIC PATHWAY 
Apoptosis is a process that occurs during 
normal development to assure correct 
morphogenesis and during the adult life to 
eliminate cells with damaged DNA or 
chromosome abnormalities. Moreover, 
apoptosis helps maintaining organism 
homeostasis as it is activated when cellular 
transformation takes place, in order to 
eliminate potentially malignant cells 
(Conradt, 2009; Favaloro et al., 2012; Fuchs 
and Steller, 2011). The pathways controlling 
apoptosis are highly conserved from flies to 
humans (Steller, 1995). Cell death 
machinery mainly consists of a family of 
proteases, caspases, activated by intrinsic 
and/or extrinsic signals (MacKenzie and 
Clark, 2012). In Drosophila, as well as in 
mammals, the intrinsic pathway is 
stimulated by intracellular death-inducing 
signals that activate pro-apoptotic proteins, 
including Reaper, Hid and Grim (RHG) 
(Wing et al., 2001), which function is to 
inhibit DIAP1 (Drosophila Inhibitor of 
Apoptosis Protein 1) (Hay et al., 1995). 
Consequently, DIAP1 cannot inhibit initiator 
caspase Dronc, which then binds to Ark 
(Apaf-1 related killer) forming the apoptosome and, ultimately, promoting cell death via the 
activation of the effector caspases Drice and Dcp-1 (Fuchs and Steller, 2011; MacKenzie and 
Clark, 2012; Steller, 1995) (Figure 8).  
 
Figure 8. The intrinsic apoptotic pathway. The 
apoptotic pathway remains latent during 
development and under an apoptotic stimuli 
expression of pro-apoptotic genes rpr, hid and 
grim is induced. The function of pro-apoptotic 
proteins is to bind to DIAP1 promoting its 
destruction. This translates into the activation of 
initiator caspase, Dronc that binds to Ark to form 
the apoptosome, leading to the activation of 
effector caspases Drice and Dcp-1 to promote cell 
death.  
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The control of both the activation and repression of the apoptotic cascade is essential for 
the survival of the organism. For example, poor activation leads to defects in morphogenesis 
and cancer while prolonged activation can be the cause of several neurodegenerative diseases 
(Favaloro et al., 2012). From the death stimuli to the activation of the effector caspases, the 
regulation of the apoptotic pathway includes precise transcriptional and post-translational 
control to assure its correct outcome (Conradt, 2009; Fuchs and Steller, 2011). Protein 
ubiquitylation functions to regulate the abundance of apoptotic proteins and, thereby, to 
control both activation and repression of the apoptotic cascade (Bergmann, 2010; Vucic et 
al., 2011). In the control of the Drosophila intrinsic cell death pathway, it has been shown 
that the RHG proteins can be ubiquitylated by DIAP1 protein promoting their degradation by 
the proteasome system(Olson et al., 2003). Moreover, it has been shown that the RHG 
proteins bind to DIAP1, a RING domain containing protein, stimulating DIAP1 
autoubiquitylation and degradation and thereby, facilitating cell death (Holley et al., 2002; 
Ryoo et al., 2002; Yoo et al., 2002). Therefore, the levels of pro-apoptotic proteins and 
DIAP1 are essential to maintain the balance between cell death and cell survival. Moreover, 
other proteins in the intrinsic apoptotic pathway, such as caspases Dronc and Drice, have 
been shown to be ubiquitylated, but the function of this post-translational modification still 
remains unclear. 
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The objectives of this thesis work were to study the functionality of the dRYBP protein, 
using Drosophila melanogaster as a model system, in two different biological processes where 
protein ubiquitylation plays an important role: epigenetic regulation of gene expression 
mediated by PcG and trxG proteins, and the regulation of the apoptotic pathway. Both of these 
mechanisms of gene regulation are crucial for cellular homeostasis and therefore, to understand 
normal and pathological development. 
 
The specific objectives of this thesis work were: 
1. Analysis of dRYBP molecular function 
2. Functional study of dRYBP in the epigenetic regulation of gene expression 
3. Functional study of dRYBP in apoptosis regulation  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1. FLY STRAINS AND GENETICS  
Fly strains containing mutant alleles used in this work were: dRYBP1(Gonzalez et al., 2008), 
Sce1(Breen and Duncan, 1986), Pc3(Breen and Duncan, 1986), dBre1kim1 (van der Knaap et al., 
2010) and dkdm2KG04325 (described in www.flybase.org). 
The GAL4/UAS system was used for overexpression and inactivation experiments (Brand 
and Perrimon, 1993). The GAL4 and UAS lines used in this work were: engrailed-Gal4 
(enGal4), scalloped-Gal4 (sdGal4), rotund-Gal4 (rnGal4), Distal-less-Gal4 (DllGal4), 
apterous-Gal4 (apGal4), hedgehog-Gal4 (hhGal4), (described in www.flybase.org), UAS-rpr-
HA (Ryoo et al., 2002), UAS-dRYBP (Gonzalez and Busturia, 2009), UAS-slimb, UAS-pall, 
UAS-DIAP1, UAS-p35, UAS-GFP, UAS-p53 (described in www.flybase.org), UAS-skpARNAi, 
UAS-slimbRNAi, UAS-p53RNAi (Transgenic RNAi Project, www.flyrnai.org/TRiP-HOME.html), 
UAS-dCul1RNAi, UAS-pallRNAi, UAS-rprRNAi (Dietzl et al., 2007).  
Generation of transgenic lines: The UAS-skpA and UAS-dCul1 transgenic lines used in this 
study were generated by injection of the pUASt-skpA and pUASt-dCul1 DNA constructs kindly 
provided by P.H. O’Farrell, University of California, San Francisco, described in (Heriche et al., 
2003) following standard Drosophila transgenic procedures and using w1118 flies as host (Rubin 
and Spradling, 1982). Resulting flies were crossed with w1118 to identify transgenic flies and the 
stock Df(1)w67c23;If/CyO;MKRS/TM6B to localize the insertion in the different chromosome and 
to balance the stocks. To differentiate previous UAS-skpA and UAS-dCul1 transgenic lines from 
the ones used in this study, we named these lines UAS-skpAOB and UAS-dCul1OB. 
Transgenic flies containing the reaper-4kb-lacZ (rpr-lacZ) (Jiang et al., 2000), puckered-
lacZ (puc-lacZ) (Martin-Blanco et al., 1998) and diap1-lacZ (Hay et al., 1995) elements were 
used as reporters for rpr, puc and diap1 expression respectively. 
Flies were grown in standard fly media and fly crosses were maintained either at 17ºC, 25ºC 
or 29ºC depending on the specific experimental requirements.  
 
2. CELL CULTURES 
Drosophila S2 and S2R+ cells were grown in standard conditions at 27ºC in Cell Growth 
Media: Schneider’s Drosophila Medium + 10% Fetal Bovine Serum (Life Technologies), 
50U/ml Penicillin and 50µg/ml Streptomycin. 
Human embryonic kidney 293 (HEK293) cells were grown in standard conditions at 37ºC in 
Dulbecco's Modified Eagle Medium (Life Technologies) supplemented with 10% fetal Bovine 
Serum (Life Technologies), 100 U/ml Penicillin and 100 mg/ml Streptomycin. 
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Table 5. Enzymes used for cloning 
3. GENERATION OF DNA CONSTRUCTS  
The plasmid pUASt-dRYBP (Gonzalez and Busturia, 2009) was used as template to amplify 
dRYBP and dRYBPΔNZF cDNAs by PCR reaction using the primers indicated in Table 4. 
Next, dRYBP and dRYBPΔNZF were cloned into NdeI/XbaI pGEX-2TKN vector (Pharmacia). 
The plasmid pUASt-skpA was used as a template to amplify skpA cDNA by PCR reaction 
using the primers indicated in Table 4 and to add the FLAG-tag. skpA-FLAG tag was cloned 
into a BamHI/NotI pCDNA-3.1 vector (Sandu et al., 2010).  
The digestion using NdeI and XbaI or BamH1 and NotI, ligation and transformation were 
done following standard procedures (Sambrook, 1989) (See Table 5 for references).  
Table 4. Primers used for cloning  
Primers   Sequence 
dRYBP Fw TTTCATATGATGGACAAGAAATCCTCGCCG 
dRYBP Rv TTTTCTAGACTAACTCCGGCTGTCGTTGCT 
dRYBPΔNZF Fw TTTCATATGGCCTCCGGATCACGGCATGGC 
dRYBPΔNZF Rv TTTTCTAGACTAACTCCGGCTGTCGTTGCT 
skpAFLAG Fw CAAGGGATCCATGCCCAGCATCAAG 
skpAFLAG Rv GCTTGCGGCCGCCTTGTCGTCATCGTCTTTGTAGTCCTTCTCCTCGCACCAC 
 
The resulting plasmids were sequenced after 
cloning to confirm the sequence and orientation 
of the gene of interest at the sequence facilities at 
the Erasmus Medical Center, Rotterdam and The 
Rockefeller University, New York. 
 
4. CELL TRANSFECTION 
Transfection was done with FuGENE 6 (Roche) according to the manufacturer's instructions. 
48h after transfection, the cells were lysed and analyzed for protein expression or used as input 
for anti-FLAG IP. skpAFLAG construct was generated for this thesis work and Rpr-HA and 
DIAP-GST (Sandu et al., 2010) vectors were a gift from Dr. Hermann Steller, The Rockefeller 
University, New York. 
 
5. dsRNA GENERATION AND RNAi-MEDIATED KNOCKDOWNS  (KD) 
pUASt-dRYBP and pUASt-skpA were used as template for PCR reaction using specific 
primers to generate double stranded RNA (dsRNA) (Table 6). dsRNA was synthesized using 
Enzyme Reference 
Adv Taq Polimerase Sigma 
NdeI NE Biolabs 
XbaI NE Biolabs 
BamHI NE Biolabs 
NotI NE Biolabs 
T4 Ligase Roche 
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the MEGAscript T7 kit (Ambion). Then dsRNA was precipitated with 3M Sodium Acetate + 
100% ethanol o/n at -20ºC. The following day, dsRNA was spinned down at maximum speed 
for 15min at 4ºC, the ethanol was removed and pellets were resuspended in 50µl of RNAse free 
H2O. For inactivation in S2/S2R+ cells, 1 million of cells were resuspended in Serum-free 
media and 15µg of corresponding dsRNA were added (GFP dsRNAi was used for the Mock). 
Samples were incubated for 60min at RT and then Schneider’s complete medium was added. 
Cells were returned to 27ºC and after 4 days samples were collected for whole protein or acid 
histone extraction.  
 
 Table 6. Primers used for dsRNA generation  
Primers  Sequence 
dRYBP Fw_1 5’-TTAATACGACTCACTATAGGGAGAGACAAGAAATCCTCGCCGGT-3’ 
dRYBP Rv 5’-TTAATACGACTCACTATAGGGAGAGTGATCGAGGAGAACTTCTGG-3’ 
dRYBP Fw_2 5’-TTAATACGACTCACTATAGGGAGAGCTGTCGTTGCTCTCGCTGAA-3’  
skpA Fw_1 5’-TTAATACGACTCACTATAGGGAGACCCAGCATCAAGTTGCAATCT-3’ 
skpA Rv 5’-TTAATACGACTCACTATAGGGAGACTTCTCCTCGCACCACTCGTT-3’ 
 
dsRNAs used for inactivation of dRING, dKDM2, PC (Lagarou et al., 2008) dBRE1 (van 
der Knaap et al., 2010) were a gift from Prof. C. Peter Verrijzer, Erasmus Medical Center, 
Rotterdam.  
 
6. PROTEIN EXTRACTION 
Cells were harvested by scraping with a cell lifter to dislodge cells from the dish and 
transferred directly into 1.5ml tubes. Then, samples were centrifuged at 1000rpm for 5min and 
washed with PBS. Cells were lysed by resuspension with 200µl of RIPA Lysis Buffer (150mM 
NaCl + 1%Nonidet P-40, 0.5% Deoxycholate + 1%SDS + 50mM Tris-HCl pH 8 + 10mM NaF 
+ 0.4mM EDTA pH 8.0, 10% Glycerol) and pushed through a needle 3 times to ensure lysis. 
Next, samples were centrifuged at maximum speed for 30min at 4ºC to pellet cell debris and 
supernatant was store at -20ºC until use. 
 
7. ACID EXTRACTION OF CORE HISTONES 
Cells were harvested and washed following the same protocol as for protein extracts (Section 
6, Experimental Procedures). In this case, cells were lysed with lysis buffer (10mM Tris-HCl 
pH 7.5 + 1mM MgCl2 + 0.5% NP-40 + minitablet of Protease inhibitors, Roche + 0.1mM DTT 
and 0.2mM PMSF) for 10min on ice and pushed through a syringe 3 times. Next, samples were 
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centrifuged at 10000rpm for 1min and the pellet was washed with wash buffer (10mM Tris-HCl 
pH 7.5 + 1mM MgCl2 + 400mM KCl, minitablet of Protease inhibitors, Roche) once. Then, 
histone extraction was performed by resuspending pellet with 50ml of extraction buffer (10mM 
Tris HCl pH 7.5 + 20% Glycerol + 0.4M HCl) for 10min on ice. Samples were centrifuged at 
10000rpm for 10min and the last step was repeated with half volume of extraction buffer. After 
that, the supernatants were pulled together and incubated with acetone o/n at-20ºC.  Finally, 
samples were spinned down, washed 3 times with acetone and pellet was resuspended in 100ml 
of 2X SDS-PAGE loading buffer. Samples were stored at -20ºC until protein detection or 
pulldown assay. 
 
8. PROTEIN EXPRESSION AND PURIFICATION  
pGEX-dRYBP-GST and pGEX-dRYBPΔNZF-GST were transformed in competent E. Coli 
strain BL21 and colonies were allowed to grow o/n. 
BL21 single colonies were inoculated into 10ml of LB + 50mg/ml Amp and grown o/n at 
37ºC. The next day 5ml of the culture were transferred into a 500ml LB + 50mg/ml Amp + 
10mM ZnCl2. Bacteria were grown until OD600=0.5 and then IPTG was added to a final 
concentration of 0.2mM and grown at 25ºC for 3h. Next, the cells were centrifuged at 4000rpm 
for 20min, the pellet was washed with 10ml of PBS and centrifuged again. To lyse the cells the 
pellet was resuspended in 10ml of lysis buffer (25mM HEPES pH 7.6 + 10% Glycerol + 0.5M 
NaCl + 0.01% NP40 + 3mM DTT + minitablet of Protease inhibitors, Roche+ 50uM ZnCl2 + 
0.2mM PMSF) + 0.015mg/ml lysozyme and sonicated 30s ON/OFF with 80% Amplitud for 
8min. Next, cells were spined at 17000rpm for 30min and supernatant was stored at -20ºC until 
use. 
For protein purification, 500µl of Glutathione Sepharose 4B beads were added per 5ml of 
lysed supernatant. Then, samples were mixed at 4ºC for 2.5h and washed 3 times for 5min with 
wash buffer (10mM Tris pH 7.5 + 1mM EDTA + 100mM NaCl + 0.2% NP40).  
For GST-pulldowns, protein purification protocol was stopped at this point.  
For antibody generation, proteins were eluted by adding 100µl of elution buffer (1xHEMG + 
0.5M NaCl + 0.01% NP40 + 10mM reduced glutathione) to the beads and then, samples were 
mixed at 4ºC for 1h. Finally, eluted samples were stored at -80ºC until sent for antibody 
generation to the Erasmus Medical Center Facility, Rotterdam.  
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9. PROTEASOME INHIBITION 
S2 cells were incubated with the proteasome inhibitors 5µM Lactacystin (Millipore) and 
50µM MG-132 (Millipore) or treated with DMSO (Mock) as a control. Cells were collected 12h 
later and proteins were extracted following previously described protocols. 
Protein extracts in these conditions were used for GST-pulldown assay and for direct protein 
detection by Western Blot (WB). 
 
10. IMMUNOPRECIPITATION 
10.1. Crossed-linked antibody IP 
Previous to immunoprecipitation, dRYBP antibody was crossed-linked to Sepharose A beads 
(GE Healthcare). For that end, 1ml of dRYBP antibody (Bejarano et al., 2005) was incubated 
with 200µl of Sepharose A beads for 30min at RT. The sample was centrifuged at 1000rpm for 
3min to pellet the beads and the supernatant was discarded. Next, 0.005g of dimethylpimelidate 
(Sigma-Aldrich) were added in 1ml of 0.2M Sodium Borate pH 9.0 and mixed for 30min at RT 
to cross-link the antibody to the beads. To stop the reaction, the beads were centrifuged at 
1000rpm for 3min and incubated with 1ml of 0.2M Ethanolamine pH 8.0 for 1h at RT. Finally 
the beads were washed twice with 1M PBS and stored at 4ºC until used for IPs.  
For immunoprecipitation, dNE (Drosophila embryonic nuclear protein extracts, a gift from 
C. Peter Verrijzer, Erasmus Medical Center, Rotterdam) were incubated with anti-dRYBP 
antibody coupled to Sepharose A beads and Sepharose A beads (non-coupled to antibody) used 
as Mock. The samples were incubating by rotating for 2h at 4ºC and centrifuged at 1000rpm for 
3min to pellet the beads. Then, the beads were washed twice with HEMG buffer (50mM 
HEPES + 0.2mM EDTA + 25mM MgCl2 + 20% glycerol) containing 200mM KCl, followed by 
1 wash with HEMG containing 400mM KCl. After each wash the tube was centrifuged at 
1000rpm for 3min to pellet the beads and the supernatant was discarded. Finally, elution buffer 
(100mM Glycine + 150mM NaCl, pH 2.5) was added to the beads and then centrifuged at 
1000rpm for 5min. The supernatants containing immunoprecipitated proteins were neutralized 
with Tris pH 9.0 and stored at -20ºC. 
 
10.2. Non crossed-linked antibody IP 
500µl of dNE were incubated with 100µl of the corresponding antibody or with pre-immune 
serum used as Mock o/n at 4ºC. The following day 100µl of Sepharose A beads (GE 
Healthcare) was added to each sample and mixed for 2h at 4ºC. Then, samples were washed 
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following the previously described procedures. Finally, 100µl of 6x SDS-PAGE loading buffer 
was added and proteins were eluted from beads by boiling samples at 95ºC for 5min. Eluted 
proteins were stored at -20ºC. 
 
10.3. anti-FLAG tag IP 
200µl of lysed HEK293 cells were incubated with 30µl of beads coupled to anti-FLAG 
antibody (Sigma) for 2h at 4ºC. Non transfected HEK293 cells were used as negative control for 
the IP. Then, samples were washed 3 times for 10min at 4ºC with the previously described wash 
buffer. Finally, 30µl of 6x SDS-PAGE loading buffer was added and proteins were eluted from 
beads by boiling samples at 95ºC for 5min. Eluted proteins were stored at -20ºC. 
 
11. GST-PULLDOWN ASSAY 
100µl of dRYBP-GST, dRYBPΔNZF-GST previously coupled to GST-Sepharose beads (GE 
Healthcare) or GST-Beads (used as Mock) were incubated with 300µl of dNE, S2 cells protein 
extracts or histone extracts, depending on the experimental design, for 2h at 4ºC. Samples were 
washed 3 times with 10 volumes of washing buffer (10mM Tris pH 7.5 + 1mM EDTA + 0.2% 
NP40 + 150mM NaCl) and proteins were eluted from beads by adding 200µl of 6xSDS-PAGE 
loading buffer and boiling samples for 5min at 95ºC. Eluted proteins were stored at -20ºC.   
 
12. WESTERN BLOT ANALYSIS 
Protein samples were separated by an 8, 12, 15 or 18% SDS-PAGE gel, depending on the 
MW of the protein to be analyzed, and then transferred to a nitrocellulose membrane 
(Whatman) following standard procedures. The membrane was incubated with blocking buffer 
(PBS containing 3% BSA) at RT for 30min and rinsed with PBT buffer (PBS containing 0.05% 
Tween-20). Next, the membrane was incubated o/n at 4ºC with the corresponding primary 
antibody (Table 7). Subsequently, the membrane was washed 3 times with PBT for 10min at RT 
and incubated with a secondary antibody for 1h at RT and then, washed again. Secondary 
antibodies (Table 8) coupled to HRP (Horse Radish Peroxidase) or to AP (Alkaline 
Phosphatase). Finally, protein detection was carried out using an ECL (Enhanced 
Chemiluminiscence) reagent detection kit (GE Healthcare Life Sciences) for HRP-coupled 
secondary antibodies and for those coupled to AP, membranes were incubated with NBT/BCIP 
(nitro-blue tetrazolium and 5-bromo-4-choloro-3-indolylphosphate) (Thermo Scientific) until 
protein was detected. To stop the developing reaction membranes were washed with distilled 
H2O. 
  41 
 Table 7. Primary antibodies used for WB 
Antibody Dilution Raised in Reference 
Anti -dRYBP 1:250 Rabbit (Bejarano et al., 2005) 
Anti-SKPA 1:1000 Rabbit (Hughes et al., 2008) 
Anti-dCUL1 1:1000 Rabbit Invitrogen 
Anti-H2A 1:500 Rabbit Abcam 13293 
Anti-H2Aub 1:250 Mouse Merck Millipore clone E6C5 
Anti-H2B 1:2000 Rabbit Upstate (Millipore 07-371) 
Anti-H2Bub 1:1000 Mouse Millipore clone 56 
Anti-H3 1:2000 Rabbit Abcam 1791 
Anti-H3K36me2 1:2000 Rabbit Upstate (Millipore 07369) 
Anti-H3K27me3 1:1000 Rabbit Upstate 07-449 
Anti-H3K4me3 1:1000 Rabbit Active Motif 39159 
Anti-H3K4me 1:500 Rabbit Abcam ab8895 
Anti-ub (FK2) 1:2000 Mouse Millipore 
Anti-tubulin 1:8000 Mouse Sigma 
Anti-PC 1:500 Rabbit (Lagarou et al., 2008) 
Anti-PSC 1:250 Guinea pig (Lagarou et al., 2008) 
Anti-dRING 1:500 Guinea pig (Lagarou et al., 2008) 
Anti-dKDM2 1:250 Guinea pig (Lagarou et al., 2008) 
Anti-dBRE1 1:1000 Rabbit (van der Knaap et al., 2010) 
Anti-PH 1:500 Rabbit (Lagarou et al., 2008) 
Anti-EZ 1:250 Guinea Pig (Lagarou et al., 2008) 
Anti-DIAP1 1:1000 Rabbit (Ryoo et al., 2002) 
Anti-p53 1:1000 Mouse Iowa Hibrydoma Bank 
Anti-rpr 1:1000 Chicken (a gift from H. Steller, unpublished) 
 
Table 8. Secondary antibodies used for WB 
Antibody Dilution Raised in Reference 
Anti-mouse-HRP 1:30000 Rabbit Sigma 
Anti-rabbit -HRP 1:5000 Donkey GE Healthcare 
Anti-chicken-HRP 1:10000 Rabbit Promega 
Anti-rabbit-AP 1:10000 Goat Sigma 
Anti-Guinea pig-AP 1:10000 Goat Sigma 
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13. X-GAL STAINING 
Imaginal discs were dissected from 3rd instar larvae in PBS solution and fixed in PBS + 0.5% 
Glutaraldehyde solution for 10min on ice. Then, imaginal discs were washed 3 times with wash 
buffer (PBS + 0,1% Triton) for 10min. Finally, imaginal discs were incubated in 1ml of 
developing solution (10mM NaH2PO4/Na2HPO4 + 150mM NaCl + 1mM MgCl2 + 3.5mM 
K4FeCN6, pH 7.4) and 30% X-GAL (Promega). Samples were incubated at 37ºC until they 
developed blue staining and then were mounted in 10% glycerol for subsequent analysis.  
 
14. IMMUNO STAINING  
Imaginal discs were dissected from 3rd instar larvae in PBS and fixed in a solution containing 
4% Paraformaldehyde + 0,1% Triton and 0,1% DOC for 30min at RT. Samples were then 
washed 3 times with wash buffer (PBS + 0,1% Triton) each for 10min and blocked with 
blocking buffer (1% BSA in PBS) for 30min at RT. Next, samples were stained with the 
corresponding primary antibody in blocking solution o/n at 4ºC. The following day samples 
were washed 3 times with wash buffer for 10min and incubated with the corresponding 
secondary antibody coupled to a fluorophore in blocking solution for 1h at RT. To-pro-3 was 
incubated for 10min for DNA staining. Finally, samples were washed 3 times for 10min and 
mounted in Vectashield (Vector Laboratories) for subsequent analysis. Tables 9 and 10 show 
antibodies used for immunostaining analysis. 
 
Table 9. Primary antibodies used for immunostaining 
Antibody Dilution Raised in Reference 
Anti-activated Caspase 3 (C3) 1:500 Rabbit Cell Signaling Technologies 
Anti-SKPA 1:500 Rabbit (Hughes et al., 2008) 
Anti-β GALACTOSIDASE  (β-GAL) 1:100 Mouse Promega 
Anti-DIAP1 1:500 Rabbit (Ryoo et al., 2002) 
Anti-UBX 1:20 Mouse Iowa Hibrydoma Bank 
 
Table 10. Secondary antibodies used for immunostaining 
Antibody Dilution Raised in Reference 
Anti-mouse Alexa 488 1:500 Donkey Invitrogen 
Anti-rabbit Alexa 488 1:500 Rabbit Invitrogen 
Anti-rabbit Alexa 555 1:500 Rabbit Invitrogen 
To-pro-3 1:500  Invitrogen 
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15. FLUORESCENCE AND X-GAL QUANTIFICATION AND STATISTICAL 
ANALYSIS 
Wing imaginal discs were stained following previously described procedures (Section 14 
Experimental Procedures) and photographed using a LSM510 confocal microscope. The wing 
disc area designated for fluorescence quantification was determined by the GFP expression 
domain driven by either the sdGal4, hhGal4 or enGal4 transgenic lines. The leg disc area 
designated for X-GAL quantification was determined by the GFP expression domain driven by 
the rnGal4 transgenic line. Fluorescence and X-GAL staining was measured and quantified 
using Fiji imaging software calculating the different Fluorescence/Area ratios. Statistical 
analysis was performed using Wilcoxon paired data test using the GraphPad Prism software. 
Data represents the mean + SEM (Standard Error of the Mean).  
 
16. IRRADIATION OF IMAGINAL DISCS 
Early 3rd instar larvae grown at 29ºC were irradiated at a dose of 2000R using a Philips X-ray 
instrument and then returned to 29ºC. Twenty-four hours after irradiation, the larvae were 
dissected and immunostained with anti-activated C3 antibody following previously described 
procedures (14). 
 
17. SCANNING ELECTRON MICROSCOPY  
Adult legs were dissected from 1 to 2 day-old flies and processed following standard 
procedures at the scanning electron microscopy facility of the Universidad Autónoma de 
Madrid.  
 
18. CUTICLE PREPARATION   
For preparation of larval cuticle, the larvae were washed with water, mounted in Hoyer and 
incubated o/n at 60ºC.  
For preparation of adult cuticles, the flies were dissected in water and incubated for 10min in 
10% KOH at 90ºC in order to eliminate the fat. Next, cuticles were washed with water, 
dehydrated with 100% EtOH and mounted in Euparal (ANSCO).  
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19. MICROSCOPY 
Immunofluorescence images were generated in a LSM510 confocal microscope and X-GAL 
staining and cuticles images were generated in a Zeiss CCD microscope. Images were 
subsequently processed using Adobe Photoshop CS5 and Fiji imaging software for 
quantification.  
 
20. SURVIVAL ASSAY  
First instar larvae were collected from egg laying plates, transferred into food vials and 
placed at 25°C. Survival was monitored over developmental time.  
 
21. QUANTITATIVE RT-PCR 
RNA was isolated from S2R+ cells and extracted using RNA isolation kit (Ambion). RT-
qPCR was performed using SYBR Green One-Step (Thermo-Scientific) in an Applied 
Biosystems 7900 Sequence Detector System. Quantified mRNA levels were expressed as 
relative fold change normalized to RP49. Primer sequences are indicated in Table 11. 
 
Table 11. Primers used for RT-qPCR  
Gene Sequence 
RP49 Fw 5’ TACAGGCCCAAGATCGTGAAG 3’ 
RP49 Rv 5’ GACGCACTCTGTTGTCGATACC 3’ 
dRYBP Fw 5’ CATGTTGACACCTGGCTCCTG 3’ 
dRYBP Rv 5’CGAAGGTGATCGAGGAGAAC 3’ 
skpA Fw 5’ CTCCCGAGGAAATACGCAAG 3’ 
skpA Fw 5’ CGGGCGAAAAGTCCTTCTTA 3’ 
Rpr Fw 5’ CCAGTTGTGTAATTCCGAACGA 3’ 
Rpr Rv 5’ GGATCTGCTGCTCCTTCTGC 3’ 
Hid Fw 5’ CATCAGTCAGCAGCGACAGG 3’ 
Hid Rv 5’ ACGAAAACGGTCACAACAGTTG 3’  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1. ANALYSIS OF dRYBP MOLECULAR FUNCTION  
The dRYBP protein (MW=17kDa) is evolutionary conserved (Bejarano et al., 2005) (Figure 
7) and contains a Ubiquitin Binding Domain (UBD) of the Nucleoporin Zinc Finger (NZF) type 
in its N-terminal (Alam et al., 2004; Bejarano et al., 2005). The NZF is a zinc-binding domain 
composed of 35 aminoacids present in several proteins involved in the ubiquitin pathway (Alam 
et al., 2004; Hicke et al., 2005; Wang et al., 2003). The NZF found in the dRYBP protein is also 
evolutionary conserved, and its mammalian homolog RYBP has been shown to be ubiquitylated 
and to interact with ubiquitylated proteins (Alam et al., 2004; Arrigoni et al., 2006) (Figure 7). 
To investigate the functionality of the UBD domain of the dRYBP protein we studied 
whether dRYBP could bind ubiquitin and also if dRYBP was capable of interacting with 
ubiquitylated proteins.  
 
1.1. The dRYBP protein is monoubiquitylated 
To analyze the functionality of the UBD domain of dRYBP, protein extracts from 
Drosophila S2 cells untreated (Mock) and treated with the proteasome inhibitors MG-132 and 
Lactacystin, were resolved by SDS-PAGE and analyzed by WB with both anti-dRYBP 
(Bejarano et al., 2005) and anti-ubiquitin antibodies (Table 7). Figure 9A shows that the dRYBP 
antibody (left panel) detects two different bands of two different MW, indicating that the 
dRYBP protein exists in two different forms, one of 17kDa and one of 25kDa. When comparing 
the WB showing dRYBP expression (Figure 9A, left panel) to the one showing Ub expression 
(Figure 9A, right panel) the band of 25kDa is detected with both antibodies. Taking in account 
that the Ub MW is 8kDa, our results suggest that dRYBP is monoubiquitylated (dRYBPub). 
Moreover Figure 9A also shows that both in the absence and presence of proteasome inhibitors 
the bands corresponding to dRYBPub show similar levels of dRYBP and Ub expression, 
indicating that levels of monoubiquitylation of dRYBP do not vary when the proteasome is 
inhibited. Therefore, dRYBP monoubiquitylation is not required for its proteasomal 
degradation.  
Thus, these results indicate that dRYBP exists in vivo in two forms: dRYBP and dRYBPub. 
RESULTS 
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1.2. The dRYBP protein interacts with ubiquitylated proteins 
To further understand the molecular functions of dRYBP and its UBD domain, we examined 
if the dRYBP protein could interact with ubiquitylated proteins and if so, wether it was done 
through its UBD domain. For that, we generated the constructs dRYBP-GST and dRYBPΔNZF-
GST for a pulldown assay (Figure 9B). The dRYBP-GST construct generates the full-length 
dRYBP protein while dRYBPΔNZF-GST is a truncated form lacking the NZF, which contains 
the predicted UBD (Gonzalez et al., 2008). The pulldown assay was performed using S2 cells 
treated with the proteasome inhibitors (Figure 9C) in order to increase the amount of 
ubiquitylated proteins in cell protein extracts (to observe the low amount of ubiquitylated 
proteins in untreated with proteasome inhibitor cell protein extracts see Appendix 1). Next, 
proteins were analyzed by WB, using an anti-ubiquitin antibody that exclusively detects linked 
 
Figure 9. dRYBP binds to ubiquitin, ubiquitylated proteins, H2A, H2B, H2Aub and H2Bub. (A) 
Immunobloting with anti-dRYBP (α-dRYBP) and anti-ubiquitin (α-Ub) antibodies of S2 cells protein 
extracts of untreated S2 cells (Mock) and treated with the proteasome inhibitors MG132 and 
Lacacystin (+Prot. Inhib.). Note that α-dRYBP detects two bands, 17kDa and 25kDa, and α-Ub 
detects the 25kDa band. (B) Scheme of the fusion proteins generated for GST-pulldown assays, 
dRYBP full length (dRYBP-GST) and a truncated version lacking the UBD (dRYBPΔNZF-GST). 
(C) GST-pulldown assay using S2 cell extracts treated with proteasome inhibitors (Input) incubated 
with GST beads (Mock) or with the fusion proteins dRYBP-GST or dRYBPΔNZF-GST. Eluted 
proteins were analyzed by WB using α-Ub antibody. Note a great amount of ubiquitylated proteins 
that bind to full length dRYBP-GST protein do not bind to dRYBPΔNZF-GST protein. (D) GST-
pulldown assays using S2 cells histone extracts (Input) incubated with GST beads (Mock) or with the 
fusion proteins dRYBP-GST or dRYBPΔNZF-GST. Eluted proteins were analyzed by WB using the 
indicated antibodies. Note that dRYBP-GST and dRYBPΔNZF-GST bind to the histones H2A, 
H2Aub, H2B and H2Bub. 
kDa 
kDa 
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ubiquitin (mono- or poly-) chains but not free ubiquitin (Figure 9C). The results show that full-
length dRYBP-GST protein interacts with ubiquitylated proteins (Figure 9C). However, 
dRYBPΔNZF-GST is not able to bind as many ubiquitylated proteins (Figure 9C) as the full-
length dRYBP-GST protein, suggesting that the NZF domain, which contains the UBD, is 
required for dRYBP to bind a significant amount of ubiquitylated proteins present in S2 cells. 
Taken together, our results suggest that dRYBP can bind ubiquitin. Moreover, our results 
indicate that dRYBP can bind ubiquitylated proteins through its NZF domain and suggest that it 
may be involved in biological processes where the ubiquitylation is in involved their regulation.   
 
1.3. The dRYBP protein interacts with histones H2A, H2B, H2Aub, H2Bub  
Central to epigenetic regulation of gene expression is histone monoubiquitylation 
(Goldknopf et al., 1975; Zhang, 2003). In particular, ubiquitylation of histone H2A is 
responsible for gene silencing (Endoh et al., 2012; Wang et al., 2004) and ubiquitylation of 
histone H2B is responsible for gene activation (Davie and Murphy, 1990; Henry et al., 2003; 
Osley, 2004). As shown in this thesis work, dRYBP is capable of interacting with ubiquitylated 
proteins (Figure 9C), so to begin to decipher the role of dRYBP in histone post-translational 
modifications we sought to study if dRYBP protein could bind to the ubiquitylated histones 
H2A and H2B (H2Aub and H2Bub) and if the UBD domain was involved in this interaction.   
We carried out GST-pulldowns with the full-length dRYBP-GST and dRYBPΔNZF-GST 
fusion proteins generated for this work (Figure 9B). However, in this case, an acid extraction of 
core histones from S2 cells was used as input for the pulldown. Eluted proteins were resolved 
by SDS-PAGE and analyzed by WB with the corresponding antibodies. Figure 9D shows that 
both full-length dRYBP-GST and dRYBPΔNZF-GST bind to H2A and H2B and the modified 
variants H2Aub and H2Bub. 
Taken together, the pulldown experiments show an interaction between dRYBP protein and 
histones H2A and H2B as well as to their ubiquitylated form, H2Aub and H2Bub. Moreover, 
the NZF domain is not necessary for this interaction, suggesting the existence of a different 
protein domain, required for H2A, H2Aub, H2B and H2Bub binding.  
 
2. FUNCTIONAL STUDY OF dRYBP IN THE EPIGENETIC REGULATION OF GENE 
EXPRESSION 
It has been previously described that the dRYBP protein is able to interact with PcG as well 
as with trxG proteins (Bejarano et al., 2005; Gonzalez et al., 2008). Moreover, our results show 
that dRYBP can bind to histones H2A and H2B as well as to the ubiquitylated variants H2Aub 
RESULTS 
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and H2Bub (Figure 9D). Therefore we further investigated the role of dRYBP in epigenetic 
regulation mediated by PcG and trxG proteins. 
 
2.1. The dRYBP protein biochemically interacts with SCE/dRING, dKDM2 and 
dBRE1 
To gain insight into the function of dRYBP in epigenetic regulation we performed a mass 
spectometry analysis to search for dRYBP interacting proteins (Simón, R. et al, manuscript in 
preparation) (Simón, 2013) using the dRYBP antibody (Bejarano et al., 2005) and Drosophila 
embryonic nuclear protein extracts (dNE). Among many different proteins, the mass spec 
revealed the interaction of dRYBP with the epigenetic repressors dRING and dKDM2 and with 
the epigenetic activator protein dBRE1 (Table 12).  
 
Table 12. Mass spectrometric analysis of the dRYBP, SCE/dRING, dKDM2 and dBRE1 proteins 
 
The SCE/dRING protein is responsible for H2A ubiquitylation (H2Aub), the histone 
modification responsible for gene repression, and is a member of the PcG complexes PRC1 and 
dRAF (Buchwald et al., 2006; Gutierrez et al., 2012; Lagarou et al., 2008; Wang et al., 2004). 
The dKDM2 protein is in charge of H2Aub as well as H3K36me2 demethylation and forms part 
of the dRAF complex together with SCE/dRING and PSC proteins (Lagarou et al., 2008). On 
the other hand, dBRE1 protein is responsible for H2B ubiquitylation (H2Bub), the histone 
modification responsible for gene activation (Henry et al., 2003; Hwang et al., 2003; Nakamura 
et al., 2011; Osley, 2004; Wright et al., 2011). Taking into account our previous results where 
dRYBP is shown to bind to H2A, H2Aub, H2B and H2Bub (Figure 9D), the interaction of 
SCE/dRING, dKDM2 and dBRE1 with dRYBP was further analyzed.  
First, we sought to confirm the interactions shown in the mass-spec analysis by Co-
immunoprecipitation (CoIP) experiments using dNE and the dRYBP antibody (Bejarano et al., 
2005). The samples were resolved by SDS-PAGE and then analyzed by WB using the 
antibodies against SCE/dRING, dKDM2 (Lagarou et al., 2008) and dBRE1 (van der Knaap et 
al., 2010) proteins (Figures 10A-B). In addition, we studied the interaction with the other PcG 
proteins PSC, PC and PH (Lagarou et al., 2008), which did not appear in the mass spectometry 
Protein MW (kDa) Mascot Score 
Nº of unique 
peptides Sequence coverage (%) 
SCE/dRING (CG5595) 48 1250 16 50.1 
dKDM2 (CG11033) 151 633 10 9 
dBRE1 (CG10542) 119.6 620 14 17 
dRYBP (CG12190) 17 346 4 40 
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data of dRYBP-interacting proteins but have been shown to form complexes with SCE/dRING 
and/or dKDM2 proteins (Lagarou et al., 2008; Schuettengruber and Cavalli, 2010; Shao et al., 
1999). As a negative control, detection of EZ protein was used and the reverse CoIPs were 
performed to validate all of the interactions (Figure 10).  
 
Figure 10. Biochemical interactions of dRYBP, SCE, dKDM2 and dBRE1. (A) dNE (Input) or pre-immune 
serum (Mock) were immunoprecipitated (IP) using antibodies against dRYBP, dRING or dKDM2. Eluted proteins 
were analyzed by WB with the corresponding antibodies. Note that dRYBP biochemically interacts with dRING and 
dKDM2 but not with PSC, PC, PH or EZ (rectangle). (B) dNE (Input) or pre-immune serum (Mock) were 
inmunoprecipitated (IP) using antibodies against dRYBP, dBRE1, dRING and dKDM2. Eluted proteins were 
analyzed by WB with the indicated antibodies. Note that dRYBP biochemically interacts with dBRE1, dRING and 
dKDM2 (rectangle), and that BRE1 does not interact with SCE, dKDM2 or EZ. (C) dNE (Input) or pre-immune 
serum (Mock) were immunoprecipitated (IP) with α−PSC, α−PC, α−PH and α−EZ antibodies. Eluted proteins were 
analyzed by WB with the indicated antibodies. Note dRYBP does not interact with the tested proteins. (D) GST-
pulldown assays performed using dNE (Input) incubated with GST beads (Mock) or the constructs dRYBP-GST or 
dRYBPΔNZF-GST. Eluted proteins were analyzed by WB with the corresponding antibodies. Note that dBRE1, 
dRING and dKDM2 proteins interact with both dRYBP-GST and dRYBPΔNZF-GST proteins. 
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Figures 10A and C show that dRYBP protein interacts biochemically with SCE/dRING and 
dKDM2 but not with PSC, PC, PH or EZ. The results confirm the interactions previously 
described between dRING and dKDM2, PSC, PC and PH (Schuettengruber and Cavalli, 2010) 
and between dKDM2, dRING and PSC (Lagarou et al., 2008) (Figures 10A and C). On the 
other hand, Figure 10 shows that dRYBP interacts biochemically with dBRE1 protein and that 
dBRE1 does not interact with SCE/dRING, dKDM2 and EZ (Figure 10B), suggesting that 
dRYBP interacts molecularly with dBRE1 independently from other PcG proteins.  
As previously shown in this thesis work, dRYBP binds to ubiquitylated proteins through its 
NZF domain (Figure 9C); therefore we studied whether this NZF domain was also involved in 
the binding of dRYBP to the PcG and trxG proteins. To solve this question we performed a 
GST-pulldown using the fusion proteins dRYBP-GST and dRYBPΔNZF-GST previously 
described in this work (Figure 9B). In this case we used dNE as input for the GST-pulldown to 
study protein interactions in the same conditions as the CoIPs (Figure 10D). The results show, 
in accordance with the results from the CoIPs experiments, that dRYBP interacts with 
SCE/dRING, dKDM2 and dBRE1 but does not associate with PSC, PC, PH and EZ (Figure 
10D). Interestingly dRYBPΔNZF-GST also binds to SCE/dRING, dKDM2 and dBRE1 but not 
to PSC, PC, PH and EZ, suggesting that the NZF domain is not required for the interaction of 
dRYBP with the PcG and trxG proteins (Figure 10D). 
Taken together, the above results show that dRYBP interacts biochemically with the 
repressor proteins dRING and dKDM2, with the activator dBRE1 and that it does no interact 
with any other PcG protein member studied (PSC, PC, PH and EZ). Therefore these interactions 
reveal that dRYBP may be defining novel protein complexes, one with dKDM2, dRING that we 
have denoted dRRK (Drosophila dRING, dRYBP and dKDM2) and a different complex with 
dBRE1, that we have denoted dRB (Drosophila dRYBP and dBRE1). Additionally, our results 
show that the NZF domain of dRYBP is not necessary for binding to the PcG and trxG proteins. 
 
2.2. dRYBP genetically interacts with Sce/dRing, dKDM2 and dBRE1 
The molecular interactions between dRYBP and SCE/dRING and dKDM2 and dBRE1 
(Figure 10), suggested a genetic interaction between these genes. We have previously shown 
that dRYBP genetically interacts with Sce/dRing (Gonzalez et al., 2008) therefore, we 
hypothesized that dRYBP could also be interacting genetically with dkdm2 to control gene 
silencing and with dBre1 to control gene activation.  
To probe this hypothesis, we studied the genetic interactions between dRYBP and Sce/dRing, 
dkdm2 and dBre1 using the homeotic phenotypes associated with the inactivation of PcG and 
trxG genes (Figure 11). We analyzed the transformation of meta (L3) and mesothoracic (L2) 
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legs into prothoracic (L1) legs (L2-L3 to L1, Figure 11A-B) as a PcG mutant-associated 
phenotype and the transformation of the fifth (A5) abdominal segment towards the forth (A4) 
abdominal segment (A5 to A4, Figure 11C-D) as a trxG mutant-associated phenotype. 
First, we analyzed the penetrance of the transformation of L2-L3 into L1 of dRYBP and 
dkdm2 double mutant flies. Neither loss of dRYBP function (Gonzalez et al., 2008), loss of 
dkdm2 function (Lagarou et al., 2008) nor the double mutant showed L3-L2 transformations to 
L1. Thus we studied the phenotypes in a sensitized mutant genetic background using Polycomb 
(Pc) mutant heterozygous mutant flies (Pc3/+). 50% of the Pc3/+ flies present L3-L2 
transformation to L1 (Figure 11E). Flies dRYBP1/dRYBP1; Pc3/+ present a similar frequency of 
the homeotic phenotype to Pc3/+ flies (Figure 11E), suggesting that dRYBP and Pc do not 
interact genetically. Flies dkdm2KG04325/Pc3 show an increase in the penetrance of the L2-L3 
transformations to L1 phenotype (90%, Figure 11E) when compared to Pc3/+ flies (50% L3-L2 
to L1, Figure 11E) suggesting, as previously described, that dkdm2 is an enhancer of Polycomb 
(Lagarou et al., 2008). When dRYBP and dkdm2 are concomitantly inactivated 
(dRYBP1/dRYBP1; dkdm2KG04325/Pc3) the frequency of the L3-L2 transformation to L1 is highly 
reduced from 90% to 26% of the flies (Figure 11E) suggesting that dRYBP counteracts the 
dkdm2-mediated repression.  
Next, we analyzed the genetic interactions with Sce/dRing. Heterozygous Sce1/+ mutant flies 
do not show L3-L2 transformation to L1 (Figure 11F, (Breen and Duncan, 1986; Gorfinkiel et 
al., 2004)) even when the dkdm2 expression is concomitantly inactivated (Sce1/dkdm2KG04325, 
Figure 11F). However, simultaneous inactivation of dRYBP and Sce/dRing (dRYBP1/dRYBP1; 
Sce1/+) produces L2-L3 transformation to L1 with a high frequency (86%, Figure 11F, 
(Gonzalez et al., 2008)) suggesting that dRYBP and Sce/dRing are enhancers of Pc. Notably, the 
penetrance of this phenotype is highly decreased from 86% to 2% when the levels of dkdm2 
expression are reduced (dRYBP1/dRYBP1; Sce1/dkdm2KG04325) (Figure 11F). Thus, these results 
indicate that dkdm2 counteracts the dRYBP/Sce-mediated repression. 
Finally, we studied the genetic interaction between dRYBP with dBre1 using the trxG 
mutant-associated phenotype A5 transformation to A4 (Figure 11C-D). We have previously 
described dRYBP1 homozygous mutant flies do not show any homeotic phenotype (Bejarano et 
al., 2005; Gonzalez et al., 2008). As shown in Figure 11G, dBre1kim1 homozygous mutant flies 
(dBre1kim1/dBre1kim1) show with high penetrance the A5 to A4 transformation (80%, Figure 
11G). However, in the absence of dRYBP (dRYBP1/dRYBP1; dBre1kim1/dBre1kim1) the penetrance 
of this phenotype is significantly decreased from 80% to 2% (Figure 11G), suggesting that 
dRYBP suppresses the activator function of dBre1. 
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Figure 11. dRYBP genetically interacts with Sce, dkdm2 and dBre1. (A) Wild type male legs (L1, L2 and L3). 
The L1 leg presents the sex comb located at the leg basitarsi (arrowhead) that is not present in L2 or L3. (B) 
dRYBP1/dRYBP1; Pc3/dkdm2KG04325 male legs with L2-L3 transformation into L1 showing ectopic sex combs on L2 
and L3 legs (arrowheads). (C) Wild type male abdomen. The A4, A5 and A6 segments are indicated. Note the 
pigmentation of A5 and A6. (D) Bre1kim1/Bre1kim1 male abdomen showing patches of de-pigmentation (arrowhead) 
in the A5 and A6 segments indicative of a partial transformation to A4. (E) Genetic interaction between dRYBP and 
dkdm2 in a Pc mutant background. Graph represents the frequency of the indicated phenotypes in flies of the 
indicated genotypes (n= 100 for all genotypes). Note that the frequency of the homeotic transformation in 
dRYBP1/dRYBP1; dkdm2KG04325/Pc3 flies is reduced in comparison to dkdm2KG04325/Pc3 flies (arrow). (F) Genetic 
interaction between dRYBP, dkdm2 and Sce. Graph represents the frequency of the indicated phenotype in flies of 
the indicated genotypes (n=100 for dRYBP1/dRYBP1; dkdm2KG04325 /+ and dRYBP1/dRYBP1; Sce1/+; n= 45 for 
Sce1/dkdm2KG04325 ; n= 70 for dRYBP1/dRYBP1; Sce1/dkdm2KG04325 ). Note that the frequency of the homeotic 
transformation in dRYBP1/dRYBP1; Sce1/dkdm2KG04325 flies is decreased in comparison to dRYBP1/dRYBP1; Sce1/+ 
flies (arrow). (G) Genetic interaction between dRYBP and dBre1. Graph represents the percentage of the indicated 
phenotype in flies of the indicated genotype (n=100 in both cases). Note that the frequency of the homeotic 
transformation in dRYBP1/dRYBP1; dBrekim1/ dBrekim flies is reduced in comparison to dBrekim1/dBrekim1 flies (arrow). 
 
Taken together, the results from the study on the genetic interaction of dRYBP, dkdm2 and 
Sce/dRing, indicate that dRYBP associates with these proteins to counteract and alleviate the 
dKDM2 and SCE mediated repression. Moreover, the results from the genetic interaction of 
dRYBP and dBre1 indicate that dRYBP associates with dBRE1 protein to counteract and 
alleviate the dBRE1 mediated activation. 
 
2.3. Biochemical function of dRYBP and dRYBP-containing complexes 
PcG and trxG proteins are known to post-translationally modify histones to maintain 
repressed or activated transcriptional states of their target genes. Each of the proteins has a 
specific biochemical activity. For instance, SCE/dRING is responsible for H2Aub (Buchwald et 
al., 2006; Cao et al., 2005; Gutierrez et al., 2012; Lagarou et al., 2008), dKDM2 is responsible 
RESULTS 
  57 
for enhancing H2Aub and for H3K36me2 demethylation 
(Lagarou et al., 2008) while dBRE1 is in charge of H2Bub 
(Hwang et al., 2003; Nakamura et al., 2011). Due to the 
interaction of dRYBP with these proteins (Figure 10) the 
biochemical function of dRYBP was analyzed as well as its 
biochemical function together with its interactors.  
 
2.3.1. dRYBP affects levels of histone post-translational 
modifications 
To study the biochemical function of dRYBP in 
epigenetic regulation we checked the levels of specific 
histone modifications in wild type Drosophila S2 cells 
(Mock) and in S2 cells where dRYBP had been inactivated 
(dRYBP Knock Down, KD) (Figure 12).  
First, we generated a dsRNA to inactivate dRYBP 
expression and subsequently analyzed the levels of dRYBP 
protein in dRYBP KD cells by WB in comparison to control 
S2 cells to confirm the efficiency of dRYBP inactivation 
(Figure 12). The results show that the levels of dRYBP 
protein in dRYBP KD S2 cells are almost completely absent 
in comparison with the levels of dRYBP in wild type cells 
(Mock).  
Next, histones were extracted from dRYBP KD S2 cells 
and the levels of post-translational modifications were 
analyzed by WB in comparison to histones extracted from 
control S2 cells (Mock). The results show that in the absence of dRYBP expression there is a 
decrease in the ubiquitylation of histone H2A (H2Aub, Figure 12**) and a decrease in the 
methylation H3K4 (H3K4me, Figure 12*). However, dRYBP inactivation does not significantly 
affect the levels of H3K36 dimethylation (H3K36me2), H3K27 trimethylation (H3K27me3), 
H4K3 trimethylation (H4K3me3) and H2B ubiquitylation (H2Bub).  
 
2.3.2. dRYBP modulates levels of H2Aub, H3K3me2 and H2Bub  
We next studied the effect of the inactivation of dRYBP together with the inactivation of 
Sce/dRingG, dkdm2 and dBre1 on the levels of histone post-translational modifications. For that 
 
Figure 12. dRYBP affects levels 
of histone post-translational 
modifications. (A) S2 cells were 
mock-treated or treated with 
dsRNA against dRYBP (KD). 
Protein extracts were analyzed by 
WB using antibodies against 
dRYBP and Tubulin. Note dRYBP 
protein levels are depleted in 
dRYBP KD in comparison to the 
Mock. Histone acid extraction was 
performed and analyzed by WB 
with the corresponding antibodies 
to label histone marks. Note 
dRYBP KD decreases levels of 
H4K3me (*) and H2Aub (**). 
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we used dsRNAs to inactivate the expression of dRYBP (dRYBP KD), Sce/dRing (dRING KD), 
dkdm2 (dKDM2 KD) (Lagarou et al., 2008) and dBre1 (dBRE1 KD) (van der Knaap et al., 
2010). The dsRNA of PC was used as a negative control to inactivate Pc expression (PC KD) 
(Lagarou et al., 2008). Double KDs were also generated using dsRNAs to concomitantly 
inactivate dRYBP and Sce/dRing expression (dRYBP+dRING KD), dRYBP and dkdm2 
expression (dRYBP+dKDM2 KD), dRYBP and dBre1 expression (dRYBP+dBRE1 KD), and 
dRYBP and Pc expression (dRYBP+PC KD). First, protein levels of single and double KDs 
were analyzed by WB and compared to protein levels in wild type S2 cells (Mock). Figure 13 
shows that all dsRNAs are highly effective inactivating the expression of their target. Moreover, 
Figure 13 shows dsRNAs only affect their targeted genes and do not produce any significant 
differences in the expression levels of the other genes. 
 
 
Figure 13. dsRNAs efficiently inactivate targeted gene expression. S2 cells were either mock-treated or 
incubated with dsRNAs against dRYBP, dRING, dKDM2 or PC for single KD (A), with dsRNAs against dRYBP 
and dRING, dKDM2 or PC for double KDs (B) and with dsRNAs against dRYBP or/and dBRE1 for single and 
double KDs (C). Protein extracts from S2 cells were analyzed by WB using the corresponding antibodies and 
α−Tubulin antibody for loading control. Note that all the tested dsRNAs inactivate gene expression of target genes 
and do not affect other protein levels.  
 
Next, histone extraction from the corresponding S2 cells was performed and the levels of 
post-translational modifications were analyzed comparing Mock, single and double KDs. Figure 
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14A shows that H2Aub is slightly decreased in dRYBP KD (35%). Moreover H2Aub levels are 
mildly reduced in dKDM2 KD (56%), severely decreased in dRING KD (95%) and not affected 
in PC KD (Figure 14A) consistent with what is known from the activity of dRING, dKDM2 and 
PC (Cao et al., 2005; Lagarou et al., 2008). Moreover, the results also show that the decrease in 
the levels of H2Aub in double KDs, dRYBP+dRING KD (88%), dRYBP+dKDM2 KD (51%) 
and dRYBP+PC KD (46%), are similar if not identical when compared to the reduction of the 
levels of H2Aub in the single dRING KD (95%), dKDM2 KD (56%) and dRYBP KD (35%) 
respectively (Figure 14A). These results suggest that dRYBP promotes, directly or indirectly, 
H2A ubiquitylation together with dRING and dKDM2. 
 
 
Figure 14. dRYBP modulates levels of H2Aub, H3K36me2 and H2Bub. (A-C) 
S2 cells mock-treated or incubated with the corresponding dsRNAs for single and 
double KDs. Histone acid extraction was prepared and WB with the corresponding 
antibodies. (A) Histones detected with α−H2Aub and with α−H2A and α−H3 as 
controls. The intensity of the bands corresponding to H2Aub and H2A was 
measured and quantified using Fiji imaging software calculating the H2Aub/H2A 
ratios. (B) Histones detected with α−H3K36me2 and α−H3 as a control. Note 
dRYBP+ dKDM2 KD levels of H3K36me2 decrease in comparison to dKDM2 KD. 
(C) Histones detected with α−H2Bub and  with α−H2B and α−H3 as controls. Note 
dRYBP+dBRE1 KD levels of H2Bub increase compared to dBRE1 KD 
 
We further analyzed the levels of H3K36me2 (Figure 14B). The inactivation of dkdm2 in 
dKDM2 KD cells produces an increase in H3K36me2 levels (Figure 14, (Lagarou et al., 2008)) 
but dRYBP KD does not affect levels of H3K36me2 (Figures 12). However, the concomitant 
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inactivation of dRYBP and dkdm2 (dRYBP+dKDM2 KD) produces a decrease of the 
H3K36me2 levels in comparison to single dKDM2 KD, which are very similar to the wild type 
levels of H3K36me2 (Figure 14B). These results suggest that inactivation of dRYBP together 
with dkdm2 counteracts the high levels of H3K36me2 induced by inactivation of dkdm2, 
suggesting that in a wild type situation dRYBP counteracts the demethylation induced by 
dKDM2 in the H3K36me2. 
Finally we analyzed the effect on H2Bub. The inactivation of dBre1 induces a complete 
depletion of H2Bub (Figure 14C, (Hwang et al., 2003; Walter et al., 2010)) and loss of function 
of dRYBP does not affect H2Bub (Figures 12 and 14C). However, the simultaneous inactivation 
of dRYBP and dBre1 expression (dRYBP+dBRE1 KD) partially restores the levels of H2Bub 
(Figure 14C). These results indicate that inactivation of dRYBP together with dBRE1 
counteracts the reduction of H2Bub induced by inactivation of dBRE1, suggesting that in a wild 
type situation dRYBP suppresses the ubiquitylation of H2B mediated by dBRE1.  
In summary, results from these experiments show that dRYBP interacts with SCE/dRING, 
dKDM2 and dBRE1 proteins but not with the PcG proteins PSC, PC, PH and EZ (Figure 10). 
Moreover, the NZF domain of dRYBP is not necessary for the interaction with these proteins 
(Figure 10D), suggesting that another dRYBP-domain may be required for it to bind to 
SCE/dRING, dKDM2 and dBRE1. In addition, our results show that dRYBP is able to 
modulate the levels of H2Aub, H3K36me2 and H2Bub (Figure 14), indicating its role in 
epigenetic regulation of gene expression mediated by PcG and trxG. Moreover, new evidence is 
emerging showing chromatin-independent functions of the PcG and trxG proteins (Lecona et 
al., 2013; Mohd-Sarip et al., 2012; Wen et al., 2014), suggesting that these proteins are involved 
in other functions in addition to the regulation of gene expression through histone 
modifications. 
 
3. FUNCTIONAL STUDY OF dRYBP IN APOPTOSIS REGULATION   
Several experimental observations implicate dRYBP protein in the regulation of apoptosis 
pathways. First, lack of dRYBP function produces a variety of phenotypes, including organ size 
reduction (Gonzalez et al., 2008). Second, high levels of dRYBP protein induce apoptosis 
(Gonzalez and Busturia, 2009), with its human counterpart RYBP/DEDAF doing so exclusively 
in transformed cells (Novak and Phillips, 2008). Third, both the fly and the vertebrate RYBP 
interact with a variety of apoptosis-related proteins (Chen et al., 2009; Gonzalez and Busturia, 
2009; Novak and Phillips, 2008; Stanton et al., 2007), however the molecular mechanisms 
controlling dRYBP/RYBP-mediated apoptosis are poorly understood. 
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3.1. dRYBP-interacting proteins include the SCF E3 ubiquitin ligase complex 
components 
To begin to decipher the function of dRYBP in the regulation of the mechanisms of cell 
death, we identified dRYBP-interacting proteins within the list of dRYBP-associated proteins 
resulting from the mass spectrometry experiments (Simón, R. et al, manuscript in preparation) 
(Simón, 2013). We found that dRYBP associates with members of the SCF E3 ubiquitin ligase 
complex (Table 13), previously shown to regulate the apoptotic pathway in mammals by protein 
ubiquitylation (Tan et al., 2006). Taking into account that the dRYBP protein contains a UBD 
(Figure 7) (Alam et al., 2004; Bejarano et al., 2005), we hypothesized that dRYBP might be 
regulating apoptosis together with the SCF complex. Thus, we sought to investigate the 
interaction with the SCF complex members. 
 
Table 13. Mass spectrometric analysis of the dRYBP, SKPA, dCUL1 and Pall proteins 
Protein MW (kDa) Mascot Score Nº of unique peptides Sequence coverage (%) 
dRYBP 
(CG12190) 17 346 4 40 
SKPA 
(CG16983) 19 320 5 47.5 
dCUL1 
(CG1877) 89.5 92 2 3.5 
Pall (CG3428) 36 118 2 6.5 
 
The SCF complex is composed by the scaffold proteins SKPA and dCUL1 and the F-box 
(Bocca et al., 2001; Jackson and Eldridge, 2002), which is responsible for substrate specificity 
(Skowyra et al., 1997) and ultimately, for different biological functions (Cardozo and Pagano, 
2004; Heriche et al., 2003; Inuzuka et al., 2011; Silverman et al., 2012). The mass spec data 
revealed that dRYBP interacts with the SCF complex proteins SKPA and dCUL1 (Table 13). 
The only F-box in the dRYBP mass-spec data was Pallbearer (Pall), previously shown to 
interact with SKPA and dCUL1 in the SCF complex to promote engulfment of cells (Ferrandon, 
2007). We analyzed the inactivation of Pall and found that it does not produce any visible 
phenotype in the wing, nor did we find that inactivation of Pall induced apoptosis in the wing 
imaginal discs (Appendix 2). Therefore, we did not study the interaction of Pall and dRYBP and 
their role in the regulation of apoptosis any further.  
Searching for other F-boxes that could form part of this complex, we found that the protein 
Slimb (Slmb) interacts with both SKPA and dCUL1 (Bocca et al., 2001). Moreover, mutant cell 
clones of slmb induce apoptosis (Miletich and Limbourg-Bouchon, 2000). Although Slmb does 
not appear in the dRYBP-mass-spec data, we selected this protein to study the interaction with 
dRYBP and the SCF complex in the regulation of apoptosis. 
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3.2. Subunits of the SCF E3 ligase complex interact with dRYBP 
First, we analyzed the biochemical interactions 
between dRYBP and SKPA and dCUL1 by Co-
immunoprecipitation of dNE using an anti-dRYBP 
antibody (Bejarano et al., 2005), followed by 
identification of the associated proteins by WB with 
antibodies against SKPA(Hughes et al., 2008) and 
dCUL1 (Table 7). Figure 15 shows that SKPA and 
dCUL1 co-immunoprecipitate with dRYBP.  We could 
not test the biochemical interaction of the F-box Slmb 
with dRYBP because there was not an anti-Slmb 
antibody available at the time when we performed the 
experiments. 
These results demonstrate the biochemical interaction 
between dRYBP and SKPA and dCUL1 and suggest that 
dRYBP participates, together with the SCF complex, in 
the process of protein ubiquitylation. 
 
3.3. dRYBP genetically interacts with the SCF complex members skpA, dCul1 and slmb 
Next, the functionality of the interactions between dRYBP and the SCF complex was studied 
by correlating the phenotypes associated with the lack of dRYBP function with the phenotypes 
associated with loss of the SCF complex function. Among other phenotypes, dRYBP 
homozygous mutants and inactivation of dRYBP in flies show a reduction of the wing size 
(Figure 16B, (Gonzalez et al., 2008)). Using this wing phenotype as readout, we analyzed the 
genetic interactions between dRYBP and the SCF complex components skpA, dCul1 and slmb. 
Because loss of function mutations in the dCul1, slmb and skpA genes are embryonic lethal 
(Jiang and Struhl, 1998; Murphy, 2003; Spradling et al., 1999), the GAL/UAS system (Brand et 
al., 1994) was used to inactivate their function in the wing imaginal disc. 
Flies sdGal4>UAS-skpARNAi/UAS-GFP show wings with a substantial size reduction (Figure 
16C) due to a decrease in the levels of SKPA protein (see Figure 17 for the efficiency of the 
UAS-skpARNAi and UAS-skpAOB transgenic lines, for the cellular localization of SKPA, the 
specificity of the anti-SKPA antibody and for additional larval phenotypes associated with loss 
of skpA function). Moreover, this small wing phenotype (Figure 16C) is not due to de-
 
Figure 15. dRYBP biochemically 
interacts with SKPA and dCUL1. 
(A) dNE (Input) were IP using 
Sepharose A beads only (Mock) or 
Sepharose A beads coupled to 
α-dRYBP antibody. The precipitates 
were analyzed by WB using antibodies 
against dCUL1, SKPA or dRYBP 
proteins. The SKPA Input sample and 
the SKPA IP sample were not diluted. 
The dCUL1 and dRYBP Input samples 
were 50% diluted while the dCUL1 IP 
and dRYBP IP samples were not 
diluted.  
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repression of the homeotic protein Ubx in the wing imaginal discs of sdGal4>UAS-skpARNAi 
larvae (Appendix 3).  
 
Figure 16. dRYBP genetically interacts with SCF complex members. (A-H) dRYBP and SCF 
complex genetic interactions. (A) Wing from control sdGal4 fly. (B) Wing from sdGal4>UAS-
dRYBPRNAi/UAS-GFP fly. Note the moderate wing size reduction compared to control (A). (C) Wing 
from sdGal4>UAS-skpARNAi/UAS-GFP fly. (D) Wing from sdGal4>UAS-skpARNAi/UAS-dRYBPRNAi 
fly. Note the increase in wing size reduction due to the simultaneous inactivation of skpA and dRYBP. 
(E) Wing from sdGal4>UAS-slmbRNAi/UAS-GFP fly. (F) Wing from sdGal4>UAS-slmbRNAi/UAS-
dRYBPRNAi fly. Note the increase in wing size reduction due to the simultaneous inactivation of slmb 
and dRYBP. (G) Heminotum of sdGal4>UAS-dCul1RNAi/UAS-GFP fly. Arrow indicates the wing 
tissue transformed into notum. (H) Heminotum of sdGal4>UAS-dCul1RNAi /UAS-dRYBPRNAi fly. 
Arrow indicates the site of wing tissue in normal flies, completely lacking in this genetic background. 
Scale bars represent 0.5mm 
 
Furthermore, simultaneous inactivation of both skpA and dRYBP in sdGal4>UAS-
skpARNAi/UAS-dRYBPRNAi larvae results in a much greater wing size reduction (Figure 16D) in 
comparison to the wing size reduction due to the individual inactivation of either gene (Figures 
16B and C), indicating the genetic interaction between skpA and dRYBP. Additionally, wings 
from flies sdGal4>UAS-slmbRNAi/UAS-GFP are not properly formed (Figure 16E) and show a 
size reduction which is much more severe in sdGal4>UAS-slmbRNAi/UAS-dRYBPRNAi (Figure 
16F). Finally, inactivation of dCul1 in the wing imaginal disc of sdGal4>UAS-dCul1RNAi/UAS-
GFP larvae results in flies with rudimentary wings showing morphological features of notum 
(Figure 16G). However in flies sdGal4>UAS-dCul1RNAi/UAS-dRYBPRNAi the transformation 
towards notum is not even present, indicating a synergistic effect between dRYBP and dCul1 
(Figure 16H).  
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Figure 17. Analysis of SKPA 
expression and skpA mutant-
associated phenotypes. (A-A’’’) 
Control y1,Df(1)w67c23 salivary gland 
showing SKPA (green) (A), To-Pro-3 
(blue) (A’) and Phalloidin (red) 
expression (A’’). (A’’’) Merged images 
(A), (A’) and (A’’). (B-B’’) UAS-
skpARNAi decreases levels of SKPA 
protein. Wing disc enGal4>UAS-
skpARNAi/UAS-GFP showing GFP 
(green) (B) expression, labeling the 
enGal4 domain in the posterior 
compartment and SKPA (red) (B’) 
expression. Note the decrease in SKPA 
expression (arrowhead) due to the skpA 
inactivation in the posterior 
compartment. (B’’) Merged images  (B) 
and (B’). Scale bars represent 100µm. 
(C-D) High levels of SKPA rescues the 
wing phenotype associated with skpA 
inactivation. (C) Wing sdGal4>UAS-
skpARNAi.(D) Wing sdGal>UAS-
skpARNAi/UAS-skpAOB. Note the complete 
rescue of the wing phenotype. (E-F) 
Inactivation of skpA induces larval 
melanotic cells. (E) Larva 
enGal4>UAS-skpARNAi showing 
melanotic cells in the heart (arrowhead) 
and salivary glands (arrow). (E’) 
Enlargement of heart melanotic cells 
shown in (E). (F) Larva enGal4>UAS-
skpARNAi showing melanotic cells in the 
gut (arrowhead). (F’) Enlargement of 
melanotic gut cells shown in (F). Scale 
bars represent 0.5 mm.  
 
Additionally, we analyzed the genetic 
interactions between dRYBP and the 
components of the SCF complex studying 
fly survival (Figure 18). The survival of 
flies where dRYBP has been 
simultaneously inactivated with skpA, 
dCul1 or slmb is significantly decreased in 
comparison to flies where skpA, dCul1, 
slmb or dRYBP have been separately 
inactivated (Figure 18). 
Hence, the results indicate that dRYBP 
genetically interacts with the SCF 
components skpA, dCul1 and slmb. 
 
 
Figure 18. Function of dRYBP and the SCF complex in 
fly survival. Survival (percentage) of flies of the indicated 
genotypes. Error bars represent SEM (standard error of the 
mean) and asterisks denote the following p values: * 
p<0.05 and ** p<0.005. 
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3.4. Inactivation of dRYBP and inactivation of the SCF complex components induces 
apoptosis  
We next investigated whether miss-regulation of apoptosis was responsible for the wing 
phenotype associated to the functional inactivation of dRYBP, skpA, dCul1 and slmb. First, we 
analyzed the expression of activated-Caspase 3 (C3) in the wing imaginal discs of 
sdGal4>UAS-dRYBPRNAi larvae (Figure 19A). The results show that C3 is expressed in a small 
number of cells in sdGal4>UAS-dRYBPRNAi wing discs (Figure 19A) in comparison to C3 
expression in wild type sdGal4 control discs (Figure 19B). This indicates that the inactivation of 
dRYBP weakly induces apoptosis in the wing imaginal disc but significantly (p<0.05) increases 
by 35% the amount of cells undergoing apoptosis by in comparison to the number of cells 
undergoing apoptosis in a wild type wing disc (Figure 19D).  
Subsequently, apoptosis was analyzed in wing discs of sdGal4>UAS-skpARNAi/UAS-GFP 
larvae and we found C3 to be expressed in a large number of cells (Figure 19E) in comparison 
to a wild type disc (Figure 19B). Additionally, high levels of C3 protein were observed when 
we inactivated skpA using other drivers, such as apGal4, and in other imaginal discs, such as the 
leg imaginal disc, which resulted in an apoptotic adult leg phenotype (Figure 20) (to observe the 
inhibition of C3 expression in the presence of high levels of the baculovirus anti-apoptotic p35 
protein (Hay et al., 1994) confirming the activation of the apoptotic pathway see Appendix 4). 
Furthermore, we found high levels of C3 expression in sdGal4>UAS-dCul1RNAi/UAS-GFP 
(Figure 19G) and sdGal4>UAS-slmbRNAi/UAS-GFP wing imaginal discs (Figure 19I), which is 
consistent with previous reports that indicated that reduced dCul1 function and mutant cell 
clones for slmb produce apoptosis(Heriche et al., 2003; Jiang and Struhl, 1998; Miletich and 
Limbourg-Bouchon, 2000).  
Taken together, the results indicate that the inactivation of dRYBP, skpA, dCul1 or slmb 
induces apoptosis in the imaginal cells and therefore, may interact to inhibit apoptosis. 
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Figure 19. Inactivation of dRYBP and the SCF complex acts synergistically to induce apoptosis in wing 
imaginal discs. arrowheads point to apoptotic cells labeled with α-C3 (red). (A) Wing disc sdGal4>UAS-
dRYBPRNAi showing C3 expression. (B) Control y1, Df(1)w67c23 wing disc showing C3 expression. (C) Wing disc 
enGal4>UAS-GFP showing the expression of GFP (green), marking of the enGal4 domain in the posterior 
compartment. (D) Quantification of C3 expression (fluorescence/area) in the anterior and posterior 
compartments of enGal4>UAS-dRYBPRNAi/UAS-GFP wing discs (n=21). Error bars represent SEM and asterisk 
denotes the following p value: * p<0.05. AU= Arbitrary Units. (E) Wing disc sdGal4>UAS-skpARNAi/UAS-GFP 
showing C3 expression. (E’) Merge of (E) with GFP (green) expression. (F) Wing disc enGal4>UAS-
dRYBPRNAi/UAS-GFP showing C3 expression. (F’) Merge of (F) with GFP (green) expression. (G) Wing disc 
sdGal4>UAS-dCul1RNAi/UAS-GFP showing C3 expression. (G’) Merge of (G) with GFP (green) expression. 
(H) Wing disc enGal4>UAS-skpARNAi/UAS-GFP showing C3 expression. (H’) Merge of (H) with GFP (green) 
expression. (I) Wing disc sdGal4>UAS-slmbRNAi/UAS-GFP showing C3 expression. (I’) Merge of (I) with GFP 
(green) expression. (J) Wing disc enGal4>UAS-GFP;UAS-dRYBPRNAi/UAS-skpARNAi. Note that the number of 
cells showing C3 expression increases in response to the simultaneous inactivation of dRYBP and skpA 
(compare (F) and (H)). (J’) Merge of (J) with GFP (green) expression. Scale bars represent 100µm. 
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Figure 20. Inactivation of skpA with numerous drivers induces C3 expression and apoptotic 
phenotypes. (A) Wing disc apGal4>UAS-skpARNAi/UAS-GFP showing GFP (green) expression, labeling 
the apGal4 domain in the dorsal compartment (A’) Wing disc apGal4>UAS-skpARNAi/UAS-GFP showing 
C3 (red) expression. Note the high amount of cells expressing C3 due to inactivation of skpA. (A’’) 
Merge of images (A) and (A’). Scale bars represent 100µm. (B) Metathoracic leg disc y1,Df(1)w67c23 
showing wild type C3 (red) expression. (C) Metathoracic leg disc dllGal4>UAS-skpARNAi showing GFP 
(green) expression, labeling the dllGal4 expression domain. (C’) Metathoracic leg disc dllGal4>UAS-
skpARNAi showing C3 (red) expression. Note the increase of cells expressing C3 in comparison to (B). 
(C’’) Merge of images (C) and (C’). (D) Prothoracic leg disc dllGal4>UAS-GFP. Scale bar represents 
200µm. (E) Prothoracic leg disc dllGal4>UAS-skpARNAi. Scale bar represents 100µm. 
 
We then asked whether the apoptosis observed in the absence of skpA was modulated when 
dRYBP function was concomitantly inactivated. We analyzed the expression of C3 in the 
posterior compartment of wing imaginal discs where the function of skpA and dRYBP was 
simultaneously inactivated using the enGal4 line (Figure 19C). The results show that C3 
expression in enGal4>UAS-GFP;UAS-skpARNAi/UAS-dRYBPRNAi (Figure 19J) is increased when 
compared to the C3 expression in either enGal4>UAS-dRYBPRNAi/UAS-GFP (Figure 19F) or in 
enGal4>UAS-skpARNAi/UAS-GFP (Figure 19H) wing imaginal discs. The increase in C3 
expression when skpA and dRYBP are simultaneously inactivated is consistent with the 
synergistic effect on the wing size reduction observed in sdGal4>UAS-skpARNAi/UAS-dRYBPRNAi 
(Figure 19D) and suggests that dRYBP and the SCF complex function together to inhibit 
apoptosis in Drosophila. 
 
3.5. The dRYBP-SCF complex regulates the intrinsic apoptotic pathway  
The results show that the inactivation of the dRYBP-SCF complex induces apoptosis (Figure 
19) and therefore this complex might be involved in the inhibition of cell death. To begin to 
decipher the molecular mechanisms by which dRYBP-SCF inhibits cell death, we asked 
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whether the apoptosis induced by loss of skpA and dRYBP function was dependent on the levels 
of expression of the components of the intrinsic apoptotic pathway; the pro-apoptotic protein 
Reaper (Rpr) (Yoo et al., 2002) and the anti-apoptotic protein DIAP1 (Hay et al., 1995) (Figure 
8) (to observe the activation of other pathways studied such as Dmp53 (Dichtel-Danjoy et al., 
2013) and the JNK pathway (Davis, 2000; Moreno et al., 2002) in the apoptosis induced by 
inactivation of skpA see Appendix 5).  
 
3.5.1. Inactivation of skpA induces rpr transcription and increases Rpr protein levels 
We used reaper-lacZ (rpr-lacZ) as a reporter of Rpr expression (Jiang et al., 2000). We 
examined β−GAL expression in wing imaginal discs of sdGal4>rpr-lacZ;UAS-skpARNAi larvae. 
Figure 21B shows that β-GAL expression is significantly up-regulated in comparison to β-GAL 
expression in a wild type rpr-lacZ wing disc (Figure 21A) by 60%, (p<0.005) (Figure 21C). 
This result indicates that SKPA directly or indirectly regulates rpr transcription. 
Furthermore, we sought to analyze the levels of expression of pro-apoptotic genes (Yoo et 
al., 2002) and their protein levels in S2 cells where skpA was inactivated. For that, we generated 
a specific dsRNA to inactivate skpA (skpA KD, Figures 21D and E) and measured the mRNA 
levels of pro-apoptotic genes rpr and hid by RT-qPCR (Figure 21D). The results show that 
inactivation of skpA in S2 cells does not affect the transcription of hid, but causes a significant 
increase in the levels of rpr mRNA (Figure 21D). The up-regulation of rpr transcription in S2 
cells is in accordance with the results observed in wing imaginal discs, where rpr-lacZ 
transcription is also up-regulated (Figure 21B) (see section 3.5.6. for explanation for dRYBP 
inactivation in S2 cells). 
Additionally, we studied the effect of inactivation of skpA on the levels of Rpr protein. For 
that, wild type S2 cells protein extracts were resolved by SDS-PAGE and analyzed by WB with 
anti-Rpr antibody (a gift from H. Steller, unpublished) and compared to S2 cells extracts were 
skpA was inactivated (skpA KD). Figure 21E shows a small but noticeable increase of Rpr 
expression in comparison to the undetectable Rpr expression in wild type S2 cells (Mock) 
(Figure 21E).  
Taken together these results suggest that the apoptosis induced by skpA inactivation induces 
high levels of rpr mRNA and of Rpr protein. 
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Figure 21. Inactivation of skpA induces rpr transcription and increases Rpr protein levels. (A) 
Wing disc reaper-lacZ (rpr-lacZ) showing β-GAL (green) expression. (B) Wing disc sdGal4>rpr-
lacZ;UAS-skpARNAi showing β-GAL (green) expression. Scale bars represent 100µm. (C) 
Quantification of β-GAL expression (fluorescence/area) in the wing imaginal discs of the indicated 
genotypes (n=20). Error bars represent SEM and asterisks the following p values: ** p<0.005. AU= 
Arbitrary Units. (D) mRNA levels of dRYBP, skpA, rpr  and hid measured by RT-qPCR in untreated 
S2 cells (Mock) or treated with dsRNA against dRYBP (dRYBP KD) or skpA (SKPA KD). Error bars 
represent SEM of 3 different biological samples and asterisks the following p values: * p<0.01 (E) 
Protein extracts from S2 cells untreated (Mock) or treated with dsRNA against dRYBP (KD) or skpA 
(KD) were resolved by SDS-PAGE and immunoblotted with α-dRYBP and α-Rpr antibodies and α-
Tubulin antibody as a loading control. Although Rpr protein levels are weakly expressed in skpA KD 
cells (*), they are significantly increased in comparison to Rpr protein levels in the Mock (**) where 
Rpr protein is undetectable. 
 
3.5.2. Inactivation of skpA-induced apoptosis is dependent on rpr expression 
Next we studied the effect of the inactivation of rpr function in the apoptosis induced by 
skpA inactivation. For that we analyzed C3 expression in wing discs where skpA was inactivated 
(sdGal4>UAS-skpARNAi/UAS-GFP) and compared it to C3 expression in wing discs where skpA 
and rpr were simulateneously inactivated (sdGal4>UAS-skpARNAi/UAS-rprRNAi) (Figure 22). To 
control the effect of dilution of the Gal4 driver and the intrinsic variability of C3 staining, 
imaginal discs from sdGal4>UAS-skpARNAi/UAS-rprRNAi and sdGal4>UAS-skpARNAi/UAS-GFP 
larvae were stained in the same tube. Figure 22B shows that the number of cells expressing C3 
is strongly reduced when rpr and skpA are simultaneously inactivated compared to the number 
of cells expressing C3 when only skpA is inactivated (compare Figures 22A and B). 
Additionally, C3 expression was quantified in the area delimited by the domain of sdGal4 in the 
wing pouch of sdGal4>UAS-skpARNAi/UAS-rprRNAi wing discs compared to sdGal4>UAS-
skpARNAi/UAS-GFP (Figure 22C). The results from quantifying C3 expression show a significant 
75% reduction (p<0.0001) of C3 expression when rpr and skpA are simultaneously inactivated 
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(Figure 22C) indicating that the apoptosis induced by the inactivation skpA is dependent on rpr 
expression. 
 
3.5.3. Overexpression of SKPA rescues the phenotype induced by overexpression of Rpr 
protein 
As shown above, skpA induced-apoptosis promotes rpr expression (Figure 21) and that this 
apoptosis is rescued when rpr is simultaneously inactivated (Figures 22B and C). To further 
characterize the functionality of the interaction between rpr and skpA, we studied whether 
overexpression of SKPA could modulate the phenotype induced by Rpr overexpression. We 
used different UAS-rpr transgenic fly lines, which were lethal, and selected UAS-rpr-HA (Sandu 
et al., 2010) because its phenotype could be modulated. Figure 22D shows that overexpression 
of Rpr in sdGal4>UAS-rpr-HA/UAS-GFP flies promotes the complete disappearance of wings, 
probably due to the induction of cell death mediated by high levels of Rpr protein (Ryoo et al., 
2002; Yoo et al., 2002). However when SKPA and Rpr are simultaneously overexpressed in 
sdGal4>UAS-rpr-HA;UAS-skpAOB flies, the wing phenotype is significantly rescued (Figure 
22E). This result indicates that high levels of SKPA inhibits the apoptosis induced by Rpr 
overexpression and also suggests that SKPA functions to inhibit apoptosis by negatively 
regulating Rpr protein levels. 
 
Figure 22. Apoptosis induced by inactivation of skpA is dependent on levels of Rpr. (A) Wing disc 
sdGal4>UAS-skpARNAi/UAS-GFP showing activated-Caspase 3 (C3) (white) expression. Arrow 
indicates apoptotic cells. (B) Wing disc sdGal4>UAS-skpARNAi/UAS-rprRNAi showing C3 (white) 
expression. Note that the number of apoptotic cells decreases in comparison to (A) (arrow). Scale bars 
represent 100µm. (C) Quantification of C3 expression (fluorescence per area) of the corresponding 
genotypes (n=20). Error bars represent SEM and asterisks denote the following p values: *** 
p<0.0001. AU= Arbitrary Units. (D) Heminotum of sdGal4>UAS-rpr-HA;UAS-GFP showing the lack 
of wing blade (arrow). (E) Wing form sdGal4>UAS-rpr-HA;UAS-skpAOB flies . Note the rescue of the 
wing phenotype compare to (D). Scale bars represent 0.5mm. 
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3.5.4. Inactivation of skpA induces diap1 transcription and decreases DIAP1 protein levels 
To determine if the anti-apoptotic protein DIAP1 was also involved in the apoptosis 
inhibition mediated by the dRYBP-SCF, we used the transgenic flies containing diap1-lacZ as a 
reporter for diap1 expression (Hay et al., 1995). Figure 23B shows that the expression of β-
GAL in sdGal4>diap1-lacZ/UAS-
skpARNAi wing discs is up-regulated in 
comparison with the expression of 
β−GAL in a control sdGal4>diap1-
lacZ wild type discs (compare 
Figures 23A and B), suggesting that 
inactivation of skpA-induced 
apoptosis affects diap1 transcription. 
Next, we studied whether the 
expression of DIAP1 protein was 
induced by inactivation of skpA. For 
that we stained with anti-DIAP1 
antibody (Ryoo et al., 2002) and 
analyzed DIAP1 expression in 
enGal4>UAS-skpARNAi/UAS-GFP 
wing imaginal discs, where skpA had 
been inactivated in the posterior 
compartment. Figure 23C shows that 
the inactivation of skpA decreases the 
levels of DIAP1 protein, suggesting 
that the apoptosis induced by loss of 
skpA function down-regulates DIAP1 
protein levels. 
Hence, the analysis of the 
regulation of diap1 expression 
indicates that inactivation of skpA 
induces diap1 transcription and 
decreases DIAP1 protein levels, 
suggesting that down-regulation of 
DIAP1 protein occurs through a post-
transcriptional mechanism. 
 
 
Figure 23. Inactivation of skpA promotes diap1 
transcription and decreases DIAP1 protein levels. (A) Wing 
disc diap1-lacZ showing β-GAL (green) expression. (B) Wing 
disc sdGal4>diap1-lacZ/UAS-skpARNAi showing β-GAL (green) 
expression (arrow). Note the increase in β-GAL expression in 
the cells where skpA has been inactivated (arrow). (C) Wing 
disc enGal4>UAS-skpARNAi/UAS-GFP showing DIAP1 (red) 
expression. Note the decrease of DIAP1 protein levels due to 
the inactivation of skpA in the posterior compartment 
(arrowhead). (C’) Merged image of (C) and GFP (green) 
expression. (D) Wing disc sdGal4>UAS-skpARNAi/UAS-GFP 
showing C3 (white) expression (arrow). (E) Wing disc 
sdGal4>UAS-DIAP1;UAS-skpARNAi showing C3 (white) 
expression. Note that the number of apoptotic cells decreases 
compared to (D) (arrow). Scale bars represent 100µm 
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3.5.5. Inactivation of skpA-induced apoptosis is dependent on DIAP1 expression 
Next, we studied the effect of DIAP1 overexpression in the apoptosis mediated by 
inactivation of skpA. For that we analyzed C3 expression in wing discs were DIAP1 was 
overexpressed and skpA simultaneously inactivated (sdGal4>UAS-DIAP1;UAS-skpARNAi) and 
compared it to C3 expression in wing discs where we only skpA was inactivated (sdGal4>UAS-
skpARNAi/UAS-GFP). We found that expression of C3 in sdGal4>UAS-DIAP1;UAS-skpARNAi 
wing imaginal discs (Figure 23E) is decreased when compared to sdGal4>UAS-skpARNAi/UAS-
GFP wing imaginal discs (Figure 23D). Thus, these results show that high levels of DIAP1 
notably reduce the number of C3 expressing cells due to the inactivation of skpA function, 
indicating that the apoptosis induced by loss of skpA function is dependent on DIAP1 levels.  
 
3.5.6. Inactivation of dRYBP-induced apoptosis is dependent on rpr and DIAP1 expression 
We next studied whether dRYBP could be regulating rpr transcription and Rpr protein levels 
using S2 cells. First we inactivated dRYBP in S2 cells using the dsRNA generated for this thesis 
(dRYBP KD) and then measured the levels of mRNA of the rpr and hid genes by RT-qPCR 
(Figure 21D). The results show that there are not significant variations in the levels of mRNA of 
rpr nor hid between wild type S2 cells (Mock) and dRYBP KD S2 cells, suggesting that 
dRYBP does not regulate the transcription of either rpr nor hid (Figure 21D). Furthermore, 
protein extracts from dRYBP KD S2 cells were resolved by SDS-PAGE and analyzed by WB 
with anti-Rpr antibody (a gift from H. Steller, unpublished). Figure 21E shows that the 
inactivation of dRYBP does not have an effect on the levels of Rpr protein. These results 
indicate that dRYBP loss of function does not regulate rpr transcription or protein levels. 
Nevertheless these undetectable effects on rpr expression may be due to the low levels of 
apoptosis observed when dRYBP is inactivated (Figure 19A).  
Furthermore we studied whether the inactivation of rpr function and the overexpression of 
DIAP1 had an effect on the inactivation of dRYBP-induced apoptosis (Figure 24). The 
expression of C3 in enGal4>UAS-dRYBPRNAi/UAS-GFP wing imaginal discs is only observed in 
a low number of cells (Figure 19F). Therefore to study if the apoptosis induced by dRYBP loss 
of function was dependent on rpr expression and DIAP1 protein levels, we analyzed the 
modulation of the penetrance of the blistered wing phenotype due to the inactivation of dRYBP, 
previously associated to apoptosis (Dichtel-Danjoy et al., 2013; Gonzalez et al., 2008). The 
results show that 70% of the flies enGal4>UAS-dRYBPRNAi/UAS-GFP, where dRYBP has been 
inactivated present blistered wings (Figures 24B and C, (Gonzalez et al., 2008)) while none of 
the enGal4>UAS-dRYBPRNAi/UAS-rprRNAi flies, where dRYBP and rpr have been simultaneously 
inactivated show blistered wings (Figure 24C). This result suggests that the apoptosis induced 
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by the loss of dRYBP function is dependent on rpr levels of expression. Furthermore, the 
penetrance of the wing blistered phenotype is also reduced (24%) in enGal4>UAS-DIAP1;UAS-
dRYBPRNAi flies, where DIAP1 has been overexpressed and dRYBP has been simultaneously 
inactivated (Figure 24C), indicating as well, that dRYBP inactivation-induced apoptosis is 
mediated by DIAP1 protein. 
 
 
Figure 24. Apoptosis induced by the inactivation of dRYBP is dependent 
on levels of Rpr and DIAP1. (A) Wild type wing (B) Wing enGal4>UAS-
dRYBPRNAi showing blister in the posterior compartment due to dRYBP 
inactivation (arrow). Scale bars represent 0.5mm. (C) Penetrance of the 
blistered wing phenotype in the corresponding genotypes. Table shows the 
percentage of flies with blistered wings. Note that inactivation of rpr and 
overexpression of DIAP1 together with dRYBP inactivation reduce the 
percentage of flies with wing blisters in comparison to flies where only 
dRYBP has been inactivated. 
 
When considered together, the results from the epistatic relationships between dRYBP and 
skpA with rpr and DIAP1 indicate that the dRYBP-SCF complex functions to inhibit the 
intrinsic apoptotic pathway. Moreover, the results also indicate that the inhibition of apoptosis 
takes place at the level of Rpr and DIAP1 proteins.  
 
3.6. SKPA protein biochemically interacts with Rpr and DIAP1 proteins 
To study the functionality of the regulation of the intrinsic apoptotic pathway by the dRYBP-
SCF complex we examined the interactions between SKPA, Rpr and DIAP1. 
To analyze the biochemical interaction between SKPA, Rpr and DIAP1 we used HEK293 
(Human embryonic kidney) cells, a line that shows high transfection efficiency. To study the 
interaction between SKPA and DIAP1 we generated an skpA-FLAG plasmid that was co-
transfected with DIAP1-GST (Sandu et al., 2010) in HEK293 cells. Moreover, to study the 
interaction between SKPA and Rpr we co-transfected with skpA-FLAG and rpr-HA (Sandu et 
al., 2010) HEK293 cells. Additionally, cells were transfected with each vector independently as 
controls. Cell extracts were then used to perform Co-IPs using anti-FLAG beads. The eluted 
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proteins were then resolved by SDS-PAGE, followed by WB analysis with the corresponding 
antibodies (Figure 25). The Co-IPs experiments show that SKPA interacts with DIAP1 protein 
as well as with Rpr protein, indicating that SKPA biochemically interacts with DIAP1 and Rpr 
(Figure 25). Notably Rpr protein levels are highly reduced in HEK293 cells co-transfected with 
skpA-FLAG and rpr-HA when compared to Rpr protein levels in HEK293 cells only transfected 
with rpr-HA, suggesting that high levels of SKPA protein reduces levels of Rpr protein (Figure 
25B). 
 
Figure 25. SKPA biochemically interacts with DIAP1 and Rpr. (A) 
HEK293 cell extracts were transfected with skpA-FLAG or DIAP1-GST 
or simultaneously co-transfected. Cell extracts were IP using α−FLAG-
beads (IP: α−FLAG). Precipitates were analyzed by WB using antibodies 
against DIAP1, GST and FLAG. (B) HEK293 cells were transfected with 
skpA-FLAG or rpr-HA or simultaneously co-transfected. Cell extracts 
were IP using α−FLAG-beads (IP:α−FLAG). The precipitates were 
analyzed by WB using antibodies against HA, FLAG and Tubulin. Note 
levels of HA (indicative of Rpr) decrease in cell extracts co-transfected 
with skpA-FLAG+rpr-HA in comparison to HA levels in cell extracts 
transfected with rpr-HA. 
 
This result is in accordance with the results obtained in the wing, where high levels of SKPA 
rescue the Rpr overexpression wing phenotype (Figure 22E), suggesting once more that SKPA 
inhibits apoptosis through the regulation of Rpr protein levels. 
 
3.7. High levels of SKPA protein inhibit developmental and stress-induced apoptosis 
To understand the mechanism of the dRYBP-SCF complex in the inhibition of apoptosis, we 
investigated whether high levels of these proteins where able to inhibit developmental 
apoptosis, a process required to achieve proper leg morphogenesis (Fuchs and Steller, 2011; 
Manjon et al., 2007). In addition we studied if the dRYBP-SCF complex could repress the 
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radiation-induced apoptosis, associated with the elimination of damaged cells (Wichmann et al., 
2006). We chose to use the overexpression of SKPA for these experiments because 
overexpression of Slmb does not produce any visible phenotype, and high levels of either 
dRYBP (Gonzalez and Busturia, 2009) or dCUL1 both induce apoptosis (Appendix 6). 
The distal part of the legs is composed of five tarsus (T1-T5, Figure 26A) separated by 
joints. The morphogenesis of joints requires the activation of cell death in specific tarsus cells 
(Manjon et al., 2007). SKPA was overexpressed using either Distal-less-Gal4 (DllGal4) or 
rotund-Gal4 (rnGal4) lines that drive expression in the distal part of the leg (Estella et al., 2008; 
Kerridge, 1988). The results show that high levels of SKPA protein interferes with leg joint 
formation both in rnGal4>UAS-skpAOB (Figures 26B and F) and DllGal4>UAS-skpAOB (Figures 
26D and H). In addition, we analyzed whether this effect was mediated by the repression of the 
intrinsic pathway of apoptosis by studying the expression of rpr-lacZ (Figures 26I-L), as a 
readout of apoptosis, in rnGal4>rpr-lacZ;UAS-skpAOB leg imaginal discs. The results show that 
rpr-lacZ expression (Figures 26I and K) is significantly (p<0.005) decreased by 33% (Figure 
26M) in the leg imaginal discs due to the high levels of SKPA expression both in the 
prothoracic (Figure 26J) and the metathoracic (Figure 26L) leg discs. These results indicate that 
skpA functions to inhibit developmental apoptosis by interfering with the intrinsic apoptotic 
pathway. 
We next analyzed whether high levels of SKPA are capable of inhibiting X-ray-induced 
apoptosis. For that we irradiated hhGal4>UAS-skpAOB/UAS-GFP larvae and then analyzed, 
quantified and compared C3 expression in the anterior and posterior compartments of wing 
imaginal discs (Figures 26N-O). The results show that C3 expression in the posterior 
compartment of hhGal4>UAS-skpAOB/UAS-GFP wing discs, where SKPA has been 
overexpressed, is significantly (p<0.001) reduced by 20% in comparison to the wild type 
anterior compartment (Figures 26N-O).  
Taken together, our results show that high levels of SKPA are capable of inhibiting both the 
developmental- and X-ray-induced apoptosis and provide further evidence that the dRYBP-SCF 
complex functions as survival factors in these processes. 
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Figure 26. High levels of SKPA inhibit developmental and X-Ray-induced apoptosis. (A-D) Distal regions of 
prothoracic legs showing tarsal segments T2-T5. Squares include the joint between T2 and T3. (A) rnGal4>UAS-
GFP. (B) rnGal4>UAS-skpAOB. (C) dllGal4>UAS-GFP. (D) dllGal4>UASskpAOB. (E-H) Enlargement of area in the 
squares indicated in (A), (B), (C) and (D) showing joint between T2 and T3. White dots indicate position of 
corresponding bristles as reference points to locate the joints (arrows) in the legs of the different genotypes. (E) 
Enlargement of (A). (F) Enlargement of (B). Note the absence of joint between T2 and T3 compared to (E). (G) 
Enlargement of (C). (H) Enlargement of (D). Note That the joint (arrow) is not properly formed compared to (G) 
(arrow). Scale bars represent 30µm. (I-J) Prothoracic leg disc rnGal4>rpr-lacZ;UAS-GFP (I) and rnGal4>rpr-
lacZ;UAS-skpAOB (J) showing β-GAL (blue) expression. Note decreased levels of β-GAL expression in (J) compared 
to (I). (K-L) Metathoracic leg disc rnGal4>/rpr-lacZ;UAS-GFP (K) and rnGal4>/rpr-lacZ;UAS-skpAOB (L) showing 
β-GAL (blue) expression. Note the decrease of β-GAL expression in (L) compared to (K). Scale bars represent 
50µm. (M) β-GAL expression quantification (fluorescence/area) in the indicated genotypes (n=25). Error bars 
represent SEM and asterisks the following p values: ** p<0.005. AU= Arbitrary Units. (N-N’’) Irradiated wing disc 
hhGal4>UAS-skpAOB/UAS-GFP showing GFP (green) (N) expression, labeling the hhGal4 domain in the posterior 
compartment, C3 (red) (N’) expression and merged image (N’’). Note the reduction of apoptotic cells (arrowhead) in 
the posterior compartment due to the high levels of SKPA. Scale bars represent 100 µm. (O) C3 expression 
quantification (fluorescence/area) in the anterior and posterior compartment of wing discs hhGal4>UAS-skpAOB/UAS-
GFP irradiated at 2000R and dissected 24h after irradiation (n=16). Note C3 fluorescence/area is significantly 
reduced in the posterior compartment due to SKPA overexpression. Error bars represent SEM and asterisks denote 
the following p values: ** p<0.001. AU= Arbitrary Units 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1. dRYBP IS A UBIQUITIN BINDING PROTEIN 
Ubiquitylation is a post-translational modification that results in the covalent attachment of 
one or several ubiquitin molecules to a lysine residue in the target protein (Ciechanover et al., 
1980; Hershko et al., 1979). The physiological outcome of protein ubiquitylation can vary, 
depending on the number of ubiquitin molecules attached and the type of linkage to one another 
from DNA repair, epigenetic regulation of gene expression, protein degradation, endocytosis or 
other functions (Chau et al., 1989; Chen and Sun, 2009). The ubiquitylation pathway regulates 
biological processes of great relevance, such as cell death (Bergmann, 2010; Tan et al., 2006), 
cell cycle (Lau et al., 2012) and the immune response (Zinngrebe et al., 2014), and has to be 
strictly regulated to assure its specificity for the target protein, as well as specify the number of 
ubiquitin molecules and how ubiquitin is attached to target proteins. Miss-regulation of 
ubiquitylation has been implicated in the pathogenesis of multiple diseases such as Parkinson’s 
and cancer (Inuzuka et al., 2011; Thompson et al., 2008); therefore targeting the ubiquitylation 
pathway is being actively investigated for discovery and drug development (Zhang and Sidhu, 
2014).  
Once a protein is ubiquitylated, the modification has to be recognized so the downstream 
biochemical reactions take place. Some of the mechanisms involving recognition of the specific 
ubiquitylated target require a ubiquitin-binding protein, which contains in its sequence a UBD 
(ubiquitin binding domain). UBDs are protein domains that non-covalently bind mono- or 
polyubiquitin chains and can be post-translationally modified by ubiquitylation. They are 
structurally diverse and have a range of binding affinities to ubiquitin. Moreover, different type 
of UBDs can recognize distinct types of ubiquitin modifications and are present in proteins that 
have different biological functions (Hicke et al., 2005) (Table 1). For instance, some of the 
UBDs that have been characterized so far are the UBA (ubiquitin associated domain), which is 
present in enzymes involved in the catalytic reactions of ubiquitylation and de-ubiquitylation 
(Hofmann and Bucher, 1996), the UIM (ubiquitin-interacting motif), present in the subunit of 
the proteasome S5a/Rpn10 responsible for proteasomal degradation (Young et al., 1998) and the 
NZF (Nucleoporin Zinc finger), present in proteins involved in different biological processes 
such as the immune response (Kanayama et al., 2004) and endocytosis (Alam et al., 2004). 
In this thesis work, we have discovered that the dRYBP protein coexists in S2 cells in two 
different forms, dRYBP and dRYBPub (Figure 9A). Consistent with this data, the UBD 
contained in RYBP protein, the vertebrate homolog of dRYBP, has also been found to be 
monoubiquitylated (Alam et al., 2004; Arrigoni et al., 2006), reinforcing the functional 
homology between these two proteins. The different functions of dRYBP and the dRYBPub 
form remain to be determined. Our results show that dRYBP monoubiquitylation is not required 
for its degradation via proteoasome (Figure 9A). This result is not surprising as protein 
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monoubiquitylation has been shown to have different roles from proteasomal degradation (Chau 
et al., 1989; Hoeller et al., 2006). Our results indicate that the dRYBP form interacts with the 
PcG and trxG proteins and with the SCF complex components (Figures 10 and 15) (discussed in 
sections 2 and 3). Perhaps the dRYBPub form affects its functionality, as it has been shown that 
monoubiquitylation of UBD-containing proteins can have a negative regulatory role, by 
promoting protein-protein interactions that prevent recognition of ubiquitylated targets (Hoeller 
et al., 2006). Alternatively monoubiquitylation of UBD-containing proteins can mediate signal 
amplification, also generated by protein interactions, or promote membrane fusion leading to 
vesicle formation and endocytosis (Alam et al., 2004; Hicke et al., 2005). Perhaps 
monoubiquitylation of dRYBP may be involved in the shuttling from the nucleus to the 
cytoplasm and could help explain the role of this protein in the immune response (Aparicio et 
al., 2013) and in apoptosis, described in this thesis work (Section 3 of the results).  
We have also found that dRYBP interacts with ubiquitylated proteins mainly through its 
NZF domain (Figure 9C). Our results shown that the dRYBPΔNZF construct, lacking the UBD, 
very poorly binds to ubiquitylated proteins in comparison to the dRYBP full length protein 
which binds numerous (Figure 9C), indicating that the UBD is indeed involved in the 
interaction with ubiquitylated proteins. Curiously, the truncated version of the dRYBP protein 
lacking its UBD, dRYBPΔNZF can also interact with histones H2A, H2Aub, H2B and H2Bub 
(Figure 9D). This result indicates that the NZF domain of the dRYBP protein is not required for 
H2Aub and H2Bub binding, although we cannot discard this domain enhances these 
interactions. Perhaps dRYBP binding to histones may be an indirect consequence of its 
interaction with PcG and trxG proteins (discussed in section 2). 
Taken together, our results suggest that dRYBP could be functioning as a ubiquitin adaptor 
protein to promote the assembly of different ubiquitylated proteins or to activate signaling 
pathways as previously described for other UBD-containing proteins. For instance, binding of 
TAB2 and TAB3 (both NZF-containing proteins) to –K63 linked polyubiquitylated proteins is 
required for the activation of the NF-kb signaling pathway (Kanayama et al., 2004). Also 
binding of the Vsp36 protein (NZF-containing protein) to ubiquitylated proteins triggers the 
endosomal pathway activation (Alam et al., 2004; Hicke et al., 2005). 
We propose that in similar way to other NZF-containing proteins dRYBP binds to 
ubiquitylated proteins through its NZF to promote protein-protein interactions leading to the 
activation of a signaling cascade, such as apoptosis (Figure 27A). 
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This would help explain why dRYBP 
is able to interact with a wide variety of 
proteins including transcription factors 
(Schlisio et al., 2002), apoptotic-related 
factors (Gonzalez and Busturia, 2009) 
and also, the diversity of biological 
processes that dRYBP is involved in 
such as the immune response, apoptosis 
and morphogenesis (Aparicio et al., 
2013; Gonzalez et al., 2008; Gonzalez 
and Busturia, 2009; Novak and Phillips, 
2008). Interestingly the NZF is not 
essential for the binding to H2A, H2Aub, 
H2B and H2Bub therefore it is to be 
determined whether this putative 
function as a ubiquitin adaptor protein is 
achieved by its NZF domain (Figure 27). 
 
2. dRYBP INTERACTS WITH PcG AND trxG PROTEINS AND MODULATES 
LEVELS OF HISTONE POST-TRANSLATIONAL MODIFICATIONS  
The PcG and trxG proteins are responsible for the maintenance of the transcriptional 
repressed and activated states respectively of target genes throughout development and during 
the adult life (Schuettengruber and Cavalli, 2010; Schwartz and Pirrotta, 2007). These proteins 
form multimeric protein complexes with a different biochemical activity (Table 1 and 2), such 
as the repressor complex PRC1 (formed by the proteins SCE/dRING, PSC, PC and PH) 
responsible for ubiquitylation of H2AK119 (H2AK118 in Drosophila) (Endoh et al., 2012; 
Gutierrez et al., 2012; Shao et al., 1999) or the activator macrocomplex COMPASS, (that 
comprise the Trx-, Trr-, dSet- and Ash1-COMPASS complexes) responsible for mono-, di- and 
trimethylation of H3K4 (Mohan et al., 2011). However, the components of each complex can 
associate to other proteins leading to variants of the canonical complexes and consequently vary 
its function. For example, the dRAF complex (composed of SCE/dRING, PSC and dKDM2) is 
a variant of the PRC1 complex that represses transcription by more efficiently ubiquitylating 
H2A than PRC1 and by demethylating H3K36me2 (Lagarou et al., 2008). In this thesis work we 
have discovered the association of dRYBP with both repressor and activator complexes and the 
functional consequences of these interactions as discuss below. 
 
Figure 27. dRYBP binds ubiquitylated proteins and 
histones H2A, H2Aub, H2B and H2Bub. (A). 
Representation of the ubiquitin adaptor function of 
dRYBP. The dRYBP protein can bind ubiquitin (red) and 
ubiquitylated proteins through its NZF domain. (B) 
Representation of the nucleosomes formed by the histones 
H2A, H2B, H3 and H4. The dRYBP protein can bind 
directly or indirectly to histones H2A and H2B and their 
modified version H2Aub and H2Bub.  
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2.1. dRYBP interactions define novel functional repressor and activating protein 
complexes 
Mass spectromery analysis performed in the laboratory (Simón, R. et al, manuscript in 
preparation) (Simón, 2013) using anti-dRYBP antibody (Bejarano et al., 2005) in wild type dNE 
pointed out that dRYBP interacts with members from the PcG and from the trxG group of 
proteins (Table 12), consistent with previous results from the laboratory (Bejarano et al., 2005; 
Gonzalez et al., 2008). Because of the findings in this thesis work, the nature of dRYBP as a 
ubiquitin binding protein and its capability of interacting with H2Aub and H2Bub (Figure 9), 
we selected among the different proteins shown in the mass spec analysis to study the 
interaction of dRYBP with SCE/dRING and dKDM2, responsible for H2Aub (Lagarou et al., 
2008) and with dBRE1, responsible for H2Bub (Hwang et al., 2003). 
We confirmed through Co-immunoprecipitation experiments that dRYBP binds to 
SCE/dRING, dKDM2 and dBRE1 (Figure 10) and that it does not interact with PSC, PC, PH 
and EZ, none of which appeared as dRYBP interactors in the mass-spec data (Simón, R. et al, 
manuscript in preparation) (Simón, 2013). Recent studies in vertebrates have shown that distinct 
subunits of PCGF (PSC homologues) can form PRC1 variants through their interaction with 
RYBP (dRYBP homolog) and also that this association prevents the incorporation of other 
PRC1 members, such as the CBX (PC homolog), PHC (PH homolog) and SCML (SCM 
homolog) proteins, identifying two PRC1 variants: a) PRC1-CBX, the canonical PRC1 
containing CBX protein and b) PRC1-RYBP, non canonical PRC1 containing RYBP protein 
(Gao et al., 2012; Morey et al., 2013; Tavares et al., 2012). Our results show that dRYBP does 
not interact with the PRC1 members PC and PH, suggesting it forms an alternative complex to 
the canonical PRC1. However, we have shown that dRYBP only interacts with one of the PRC1 
components, the SCE/dRING protein, suggesting that the composition of the different PcG 
complexes is not conserved from fly to vertebrates. Curiously, we have shown that dRYBP and 
PSC do not biochemically interact (Figures 10A and C) and since dRYBP binds to SCE/dRING 
and dKDM2 but not to PSC, all three members of the dRAF complex, our finding suggests that 
dRYBP could be forming and alternative complex to dRAF with SCE/dRING and dKDM2 
excluding PSC that we have named dRRK (dRING, dRYBP and dKDM2) complex. We still do 
not know the relevance of the absence of PSC, an E3 ligase that promotes H2Aub and also 
stimulates the H2Aub activity of the SCE/dRING (Buchwald et al., 2006; Cao et al., 2005; 
Lagarou et al., 2008), in the putative dRRK complex but it will be discussed below in section 
2.3. Interestingly the dRAF complex is considered to be the homolog of the mammalian BCOR 
complex (Huynh et al., 2000; Lagarou et al., 2008), which contains the RYBP and BMI-1 (PSC 
in Drosophila) proteins. However, our results show that this is not the case (Figure 10) further 
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indicating that the composition of the dRYBP-containing complexes does not seem to be 
conserved between Drosophila and vertebrates. 
Furthermore, we have shown that dBRE1 biochemically interacts with dRYBP but not with 
SCE/dRING and dKDM2 (Figure 10C), suggesting the existence of a dRYBP-dBRE1 (dRB) 
complex independent from other PcG proteins. Moreover, dRYBP did not interact in the mass 
spectrometry analysis with Rad6 protein, the E2 conjugating enzyme that interacts with dBRE1 
to ubiquitylate H2B (Hwang et al., 2003; Kao et al., 2004; Robzyk et al., 2000). Perhaps the 
dRYBP protein impedes Rad6 from interacting with dBRE1 protein, as discussed below in 
section 2.3. 
Interestingly the pulldown assay shows that the association of dRYBP to SCE/dRING, 
dKDM2 and dBRE1 does not require the NZF domain (Figure 10D). This suggests that a 
different specific domain is responsible for this interaction, however we cannot discard that the 
NZF may enhance the interaction between dRYBP and the SCE/dRING, dKDM2 and dBRE1 
proteins. Moreover the association of dRYBP to PcG and trxG may indirectly mediate its 
binding to H2A, H2Aub, H2B and H2Bub. In vitro binding experiments should be carried out to 
investigate what dRYBP-domain is necessary for the binding to PcG and trxG proteins and to 
histones, and also to study if the binding to histones is direct or indirect.  
 
2.2. dRYBP modulates levels of histone post-translational modifications  
Post-translational modifications of histones are responsible for chromatin remodeling and 
therefore, are ultimately responsible for gene transcriptional repressed and activated states. 
Among the better-characterized histone post-translational modifications and of interest for this 
thesis are the monoubiquitylation of H2A (H2Aub) the mono-, di- and trimethylation of H3K36 
and the monoubiquitylation of H2B (Henry et al., 2003; Muller et al., 2002; Shilatifard, 2006; 
Wang et al., 2004). 
SCE/dRING protein is the major E3 ubiquitin ligase responsible for H2Aub (Buchwald et 
al., 2006; Gutierrez et al., 2012). Our results demonstrate that the inactivation of dRYBP in S2 
cells decreases the levels of H2Aub (Figures 12 and 14A) indicating that dRYBP promotes 
H2Aub, a landmark for gene silencing (Wang et al., 2004). This result together with the results 
from the genetic interactions, which show that that dRYBP enhances the repressor effect of 
Sce/dRing (Figure 11F), indicate that dRYBP is required for gene repression. We have shown 
that dRYBP binds to H2A and H2Aub (Figure 9D), yet dRYBP does not contain a 
ubiquitylating catalytic domain, therefore we propose that the role of dRYBP in H2Aub may be 
through its interaction with SCE/dRING by enhancing its E3 ubiquitin ligase activity. We could 
not test this possibility as the inactivation of Sce/dRing already shows a nearly complete 
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depletion of H2Aub (Figure 14A) and an increase in the reduction of H2Aub levels when 
dRYBP was simultaneously inactivated was very difficult to appreciate (Figure 14A). 
Accordingly, recent data has shown that RYBP is an essential cofactor required for 
ubiquitylation of H2A by RING1B as its inactivation reduces levels of H2Aub, supporting the 
role of dRYBP in gene repression through H2Aub (Tavares et al., 2012). 
Furthermore, previous results show that the dKDM2 protein enhances transcriptional 
repression by promoting H2Aub by dRING, a mark for gene repression, and by H3K36me2 
demethylation, counteracting the activating mark established by trxG (Lagarou et al., 2008). 
These biochemical activities of dKDM2 lead to a decrease in levels of H2Aub and to an 
increase of H3K36me2 when dkdm2 is inactivated ((Lagarou et al., 2008), Figure 14B). 
However when dRYBP is inactivated the levels of H3K36me2 are not affected (Figure 12). 
Interestingly, the levels of H3K36me2 are reduced when dRYBP and dkdm2 are simultaneously 
inactivated in comparison to the high levels of H3K36me2 when dkdm2 is inactivated (Figure 
14B). This result is consistent with the genetic results presented in this work showing that 
dRYBP counteracts dkdm2 function in the control of homeotic gene expression (Figures 11E 
and F).  
Taken together our results suggest that dRYBP functions to counteract the repressor effects 
mediated by dKDM2, but the function of dRYBP in H3K36me2 demethylation while 
biochemically interacting with dKDM2 remains to be determined. It is known that H2Aub and 
H3K36me2 demethylation are two independent biochemical reactions (Lagarou et al., 2008). 
Therefore we propose that the physical interaction between dRYBP and dKDM2 is what 
counteracts the repressor effect of dKDM2. Perhaps, the binding of dRYBP protein to dKDM2 
blocks or changes the conformation of its JmjC domain, required for H3K36me2 demethylation 
activity (Klose et al., 2006; Tsukada et al., 2006), and impedes dKDM2 to efficiently 
demethylate H3K36me2. Further studies should be carried out to clarify the function of dRYBP 
on the H3K36me2 demethylation mediated by dKDM2. 
On the other hand, we have shown that the inactivation of dRYBP affects the levels of 
H3K4me, a landmark responsible for gene activation, indicating the role of dRYBP in 
transcriptional gene activation. dRYBP did not interact in the mass spectrometry analysis with 
the Trr protein, responsible for H3K4me (Herz et al., 2013), however it interacts with other 
components of the dCOMPASS complexes, thus this putative interactions should be analyzed to 
help us understand the dRYBP function in H3K4me.  
Finally, we have shown that dBre1 inactivation induces A5 transformation to A4, a trxG 
mutant-associated phenotype. This homeotic phenotype, here described for the firs time, in 
dBre1 homozygous mutants indicates that dBRE1 should be considered as a trxG member.  
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Additionally, we have demonstrated that dRYBP inactivation does not vary levels of H2Bub 
(Figure 12). However, when dRYBP is concomitantly inactivated with dBre1, the levels of 
H2Bub are increased in comparison to the levels of H2Bub in dBre1 inactivation (Figure 14C). 
Thus dRYBP is able to partially restore the levels of H2Bub indicating that dRYBP counteracts 
dBRE1 function and this is consistent with the genetic results presented in this work indicating 
that dRYBP suppresses the activator effect of dBre1 (Figure 11G). It remains unclear how 
dRYBP can counteract dBRE1 function. Perhaps the interaction of dRYBP protein with dBRE1 
blocks partially the RING domain of dBRE1 preventing it from efficiently ubiquitylating H2B. 
Alternatively, the binding of dRYBP to H2B and H2Bub (Figure 9D) might be what inhibits 
dBRE1 E3 ubiquitin ligase activity, suggesting in this case that the role of dRYBP as a ubiquitin 
binding protein would be to impede dBRE1 from ubiquitylating H2B. 
Taken together, the results from the genetic interactions and the analysis of the modulations 
of levels of post-translational histone modifications suggest that dRYBP is responsible for 
regulating gene transcriptional repression and gene transcriptional activation. 
 
2.3. A model for dRYBP function in the epigenetic regulation of gene expression 
The results from the analyses of the dRYBP-biochemical interactions, the genetic studies 
and the investigations of the effects on the levels of histone post-translational modifications 
reveal the modulation of repressed and activated transcriptional states mediated by dRYBP 
protein. These findings have made us propose a model whereby dRYBP is involved in the 
epigenetic regulation of gene expression by promoting intermediate levels of gene 
transcriptional repression and gene transcriptional activation (Figure 28). In this scenario 
dRYBP would alleviate the repression executed by the dRAF complex and also the activation 
executed by the dBRE1 protein.  
In this model dRYBP binds to SCE/dRING and dKDM2 proteins, both members of the 
dRAF complex, excluding PSC to form the dRRK complex (Figure 28), as dRYBP does not 
biochemically interact with PSC (Figure 10). The biochemical function of this complex would 
be to promote ubiquitylation of H2A, as we an others have shown inactivation of each 
component decreases levels of H2Aub (Figure 14A, (Lagarou et al., 2008; Tavares et al., 
2012)). Ubiquitylation of H2A by the dRRK complex could be either by enhancing the E3 
ubiquitin ligase of SCE/dRING and/or by the ubiquitin adaptor function of dRYBP, which 
would recruit the dRRK complex to the H2A leading to H2Aub. However, it would not reach 
the levels of H2Aub mediated by dRAF, as dRYBP binding excludes PSC, an E3 ubiquitin 
ligase that enhances but also ubiquitylates H2A itself. Furthermore, the interaction between 
dRYBP and dKDM2 would impede dKDM2 to efficiently demethylate H3K36me2. Therefore 
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the dRRK complex would be unable to effectively repress gene expression both by its effects on 
H2Aub and H3K36me2. This would generate an intermediate state of gene transcriptional 
repression where there are high levels of H2Aub and intermediate levels of H3K36me2 in 
comparison to the efficient gene repression generated by the dRAF complex, where there are 
high levels of H2Aub and high levels of demethylated H3K36me2 (H3K36me) (Figure 28). 
On the other hand, we propose that dRYBP protein would bind to dBRE1 to form a different 
transcriptional activator complex as these two proteins biochemically interact independently 
from other PcG proteins (Figure 10). In this case either the physical interaction of dRYBP and 
dBRE1 or the interaction between dRYBP and H2B would lead to an inefficient H2Bub by 
dBRE1 (Figure 28), a histone landmark required for the recruitment of other transcriptional 
activators (Nakanishi et al., 2009; Sun and Allis, 2002). This is supported by the genetic 
interaction between dRYBP and dBre1 and the modulation of H2Bub levels when we 
simultaneously inactivate dRYBP and dBre1 (Figures 11G and 14C). Thus we propose that the 
dRYBP-dBRE1 complex (dRB) would generate an intermediate state of gene activation where 
there are intermediate levels of H2Bub and cannot efficiently recruit the COMPASS complexes, 
in comparison to a state of gene activation where dBRE1 does not interact with dRYBP and is 
able to efficiently ubiquitylate H2B, consequently recruiting the COMPASS complexes to di- 
and trimethylate H3K4 contributing to transcriptional activation (Figure 28). 
 
 
Figure 28. Proposed model for the function of dRYBP in epigenetic regulation. dRAF complex formed by the 
proteins PSC, dRING and dKDM2 generate transcriptional repressed states by ubiquitylation of H2A, leading to 
high levels of H2Aub (indicated with an arrow) and by demethylation of H3K36me2, leading to high levels of 
H3K36me. dRRK formed by dRYBP, dRING and dKDM2 also generate transcriptional repressed states by 
promoting H2Aub. However the absence of PSC, an H2A E3 ubiquityl ligase, decreases the levels of H2Aub and 
the interaction of dRYBP and dKDM2 leads to an inefficient demethylation of H3K36me2, leading to intermediate 
state of gene repression with lower levels of H2Aub and intermediate states of H3K36me2 and H3K36me. dRB 
complex is formed by the dRYBP and dBRE1 proteins. This complex inefficiently ubiquitylates H2B (H2Bub) and 
consequently cannot efficiently recruit COMPASS complexes to di- and tri-methylate H3K4, generating an 
intermediate state of gene activation. The absence of dRYBP promotes an efficient H2Bub by dBRE1 (indicated 
with an arrow), which recruits the COMPASS complexes, leading to state of gene activation with high levels of 
H2Bub and trimethylated H3K4 (H3K4me3). 
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Our findings reveal for the first time, that the interaction of dRYBP with SCE/dRING and 
dKDM2 promotes attenuation of the levels histone modifications associated with gene 
repression and also that the interaction of dRYBP with dBRE1 promotes attenuation of the 
levels histone modifications associated with gene activation. This strongly suggests that the 
presence of dRYBP in these complexes is required to promote intermediate levels of gene 
expression. This is the first time that an ETP protein has been shown to have a direct function in 
post-translational modification of histones, in particular by modulating repressed and activated 
gene transcriptional states. This thesis work points out the relevance of studying epigenetic 
regulation by ETPs, as perhaps the dRYBP function could be extended to other ETPs and could 
help understand the plasticity of epigenetic regulation of gene expression. 
Moreover this thesis work indicates the relevance of intermediate states of gene expression. 
For instance, the homeotic gene Ubx is differentially expressed in the Drosophila embryo, in the 
PS4 it is repressed, in the PS5 it shows intermediate levels of expression and in the PS6 it is 
activated. We propose the dRYBP is responsible for the intermediate repressive and activating 
transcriptional states and is a key balancer in the regulation mediated by PcG and trxG. 
Supporting this idea, mammalian PRC1 RYBP-containing complexes are proposed to mediate 
low gene repression opposed to other PRC1 non RYBP-containing complexes that promote high 
gene repression (Morey et al., 2013). Further analysis should be carried out to validate this 
model, which would help us understand the plasticity and the capability of transcription-
dependent functions of PcG and trxG proteins in normal and pathological development. 
 
3. A NOVEL dRYBP-SCF COMPLEX FUNCTIONS TO INHIBIT APOPTOSIS  
Programmed cell death is not only critical for development and tissue homeostasis, but also 
for cancer progression, where acquired resistance to apoptosis contributes to the progression of 
the disease (Favaloro et al., 2012; Kelly and Strasser, 2011). The apoptotic pathways remain 
latent during development and are activated upon intrinsic or extrinsic apoptotic stimuli. Thus, 
the balanced expression of pro- and anti- apoptotic proteins has to be strictly controlled to 
promote cell survival or to promote cell death (Conradt, 2009; Favaloro et al., 2012; Fuchs and 
Steller, 2011). Protein ubiquitylation is emerging as a central mechanism in the regulation of 
apoptosis, controlling the amounts of pro-apoptotic and anti-apoptotic factors by promoting 
protein proteasomal degradation and, thereby regulating the apoptotic pathways (Bergmann, 
2010; Vucic et al., 2011).  
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3.1. dRYBP interacts with the SCF complex to prevent apoptosis 
In this thesis work, we have investigated the function of dRYBP and the SCF E3 ubiquitin 
ligase complex in the control of apoptosis. Our main finding is the discovery of the interaction 
between dRYBP and the SCF complex and their function in the inhibition of apoptosis (Table 
13, Figures 15 and 18). This identifies a novel anti-apoptotic function for these proteins. 
Furthermore, our results suggest that dRYBP should be considered a member of the SCF E3 
ligase family that promotes the ubiquitylation of many proteins (Cardozo and Pagano, 2004). As 
both dRYBP and the SCF complex are evolutionary conserved (Figure 7) (Bejarano et al., 2005; 
Bocca et al., 2001) it is also possible that the RYBP vertebrate protein is a member of the SCF 
complex in mammals highlighting once more the importance of Drosophila to discover new 
protein functions of the components of signaling pathways  
The SCF complexes are RING-type E3-ligases that consist of the Skp1 and Cullin proteins 
as well as a variable F-box (Cardozo and Pagano, 2004; Jackson and Eldridge, 2002; Skowyra 
et al., 1997). It remains to be determined whether dRYBP is a constitutive component of the 
SCF complex, or if it is recruited to the SCF complex upon apoptotic and or survival stimuli. 
We favor the idea that it is a constitutive component as our Co-IP experiments are done in wild 
type embryonic nuclear protein extracts. We have demonstrated the biochemical interactions of 
dRYBP with SKPA and with dCUL1 (Figure 15), both core members of the SCF complex 
(Bocca et al., 2001; Jackson and Eldridge, 2002). Moreover, we have also found the synergistic 
genetic interaction between dRYBP and SKPA and dCUL1 proteins to inhibit apoptosis 
(Figures 16 and 18). The specification of the protein targeted for degradation depends of the F-
box recruited to the complex (Skowyra et al., 1997). Results from the mass spectrometry 
analysis performed by dRYBP-immunoprecipitation of embryonic nuclear protein extracts 
(Simón, R. et al, manuscript in preparation) (Simón, 2013) detected very few F-box proteins 
interacting with dRYBP. This is perhaps due to the cellular and/or temporal context of the 
interaction. We chose to study the genetic interaction between dRYBP and the F-box protein 
Slmb as we and others have shown that lack of slmb function induces apoptosis (Figure 19, 
(Miletich and Limbourg-Bouchon, 2000). We also find a synergistic genetic interaction between 
dRYBP and slmb (Figures 16F and 18). These results lead us to propose that dRYBP-SCFSlmb 
complex functions in Drosophila to inhibit apoptosis. This proposition may seem to contradict 
previous reports where SCF complexes containing different F-boxes in Drosophila were 
suggested to promote pro-apoptotic activity. For example, the SCFMorgue complex promotes 
DIAP1 ubiquitylation and its proteasomal degradation in the eye imaginal disc (Hays et al., 
2002) and the SCFNutcracker complex has been shown to function in caspase activation during 
sperm individualization (Bader et al., 2010). We propose that this is not a contradiction but it is 
due to the effect of the different F-boxes that can act as a SCF member. Indeed, SCFbTrCP, the 
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mammalian homolog of the SCFSlmb in Drosophila, has been shown to promote Pro-Caspase 3 
ubiquitylation–mediated degradation, thus protecting cells from apoptosis and functioning as a 
survival complex (Tan et al., 2006), similarly to the function we propose here for the dRYBP-
SCFSlmb complex. 
We show that loss of dRYBP function induces cell death in a low but significant number of 
cells (Figures 19A and D) and that this activity is significantly increased when skpA is also 
inactivated (Figure 19J). An accumulating body of genetic and molecular evidence is supportive 
of a role for dRYBP/RYBP/DEDAF-conserved family in the regulation of apoptosis (Chen et 
al., 2009; Danen-van Oorschot et al., 2004; Gonzalez and Busturia, 2009; Novak and Phillips, 
2008; Pirity et al., 2005; Stanton et al., 2007; Stanton et al., 2006; Zheng et al., 2001). Flies 
lacking the dRYBP function in Drosophila present either blistered or small wings (Figures 16B 
and 24, (Gonzalez et al., 2008)) and mice embryos lacking Rybp function are not able to trigger 
full decidualization, a process that requires apoptosis to complete (Joswig et al., 2003; Pirity et 
al., 2005). Additionally, inactivation of Yaf2, the zebrafish RYBP related protein, induces cell 
death in a dosage dependent morpholant manner (Stanton et al., 2006). Moreover, the dRYBP 
conserved protein family has been shown to interact with a range of apoptotic-related proteins, 
which include DD (Death Domain) and DED (Death Effector Domain) domain-containing 
proteins (Gonzalez and Busturia, 2009; Zheng et al., 2001), Apoptin (Danen-van Oorschot et 
al., 2004) and Hippi (Stanton et al., 2007). Furthermore, murine RYBP has been shown to be a 
regulator of the MDM2–p53 loop exhibiting tumor suppressor activity (Chen et al., 2009). 
Taken together, these observations provide ample evidence for the involvement of dRYBP in 
the control of apoptosis. Our results showing the interaction of dRYBP with the SCFSlmb 
complex described in this thesis provides a clear starting point to begin to decipher dRYBP 
mechanisms of apoptosis inhibition in Drosophila as well as in other organisms. 
 
3.2. dRYBP-SCF complex functions to regulates the intrinsic apoptotic pathway  
Our results also show that loss of dRYBP-SCFSlmb complex function has a pro-apoptotic role 
during wing development in Drosophila (Figure 16). A previous report suggested that the 
absence of imaginal discs in skpA mutant flies was due to apoptosis in imaginal cells (Murphy, 
2003). Our results demonstrate that SKPA protein has a survival role during wing development 
(Figure 16C) acting synergistically with the dRYBP protein (Figure 16D).  
In addition, we have shown that the apoptosis in both loss of dRYBP and skpA function is 
dependent on levels of pro-apoptotic gene rpr and anti-apoptotic protein DIAP1 (Figures 22, 23 
and 24), indicating their role in the regulation of the intrinsic apoptotic pathway. When studying 
the regulation of the components of the intrinsic apoptotic pathway, we found that inactivation 
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of dRYBP does not produce any variations in rpr mRNA or protein levels (Figure 21D), which 
is probably due to the low levels of apoptosis induced in these conditions (Figures 19A, D and 
F). However inactivation of skpA promotes transcriptional activation of rpr expression (mRNA 
in S2 cells and rpr-lacZ in wing imaginal discs, Figures 21A-D) and also the up-regulation of 
Rpr protein (Figure 21E), which raised the question whether the inhibition of apoptosis 
mediated by dRYBP-SCFSlmb complex, is at a transcriptional or at a post-translational level.  
Several experimental observations made us favor the idea that the dRYBP-SCFSlmb-mediated 
apoptosis inhibition occurs through post-translational regulation. First, it has been previously 
described that activation of the intrinsic apoptotic pathway up-regulates the transcription of the 
pro-apoptotic genes such as rpr (Shlevkov and Morata, 2012) and the transcription of anti-
apoptotic gene diap1 (Ryoo et al., 2002). We show that inactivation of skpA promotes up-
regulation of rpr and diap1 transcription (Figures 21 and 23B) whereas it promotes an increase 
in Rpr (Figure 21E) and a decrease in DIAP1 protein levels (Figure 23C). We propose that the 
observed activation of rpr and diap1 transcription is a consequence of the activation of the 
intrinsic apoptotic pathway. Subsequently, Rpr protein levels increase (Figure 21E) that, in turn, 
repress DIAP1 protein leading to the activation of the apoptotic pathway. Second, our results 
show that SKPA protein directly interacts with both DIAP1 and Rpr proteins (Figure 25), 
further supporting a post-translational regulation through SKPA, DIAP1 and Rpr protein 
interactions. Third, overexpression of SKPA in HEK293 cells decreases the levels of Rpr 
protein (Figure 25B). It is known that protein levels of Rpr are regulated by ubiquitylation 
(Olson et al., 2003), thus the decrease in Rpr protein levels when co-transfected with SKPA 
suggests that Rpr protein is being degraded and also, that this occurs through its ubiquitylation 
by the SCF complex (Figure 29). Finally, the nature of the dRYBP-SCFSlmb complex is to 
catalyze the last step of the ubiquitylation reaction of the target protein committed for 
proteasomal degradation (Cardozo and Pagano, 2004; Heriche et al., 2003; Inuzuka et al., 2011; 
Jackson and Eldridge, 2002; Tan et al., 2006) therefore, dRYBP-SCFSlmb probably does not 
directly regulate transcription and it is most likely to function post-translationally modifying 
proteins for proteasomal degradation. 
Consistent with the conclusion that high levels of SKPA protein decrease Rpr protein levels 
(Figure 25B), we also found that SKPA overexpression is capable of rescuing the effects of 
overexpression of Rpr (Figure 22E) and, also capable of inhibiting developmental-induced and 
radiation-induced apoptosis (Figure 26), further supporting its function in the inhibition of 
apoptosis. Curiously, high levels of dRYBP and dCUL1 also induce apoptosis (Appendix 6, 
(Gonzalez and Busturia, 2009)). This paradox could be explained through the interaction of 
dRYBP with several apoptotic-related proteins (Danen-van Oorschot et al., 2004; Gonzalez and 
Busturia, 2009; Stanton et al., 2007; Zheng et al., 2001). Alternatively, due to the nature of 
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dRYBP protein as a ubiquitin adaptor protein and of dCUL1 as a scaffold protein, perhaps high 
levels of these proteins recruit an excess of SCF complex components through a dominant-
negative mechanism, thus interfering with SCF complex function in the inhibition of apoptosis. 
Taken together, our results indicate that the inhibition of apoptosis mediated by the dRYBP-
SCFSlmb complex takes place through the regulation of the components of the intrinsic apoptotic 
pathway. Therefore, we have proposed a model (Figure 29) explaining the function of the 
dRYBP-SCFSlmb complex in the regulation of apoptosis, whereby dRYBP functions as an 
ubiquitin adaptor protein facilitating the interaction and/or assembly of SCF complex members 
upon survival stimuli. In this model the dRYBP-SCFSlmb complex may control the ubiquitylation 
of Rpr and its proteasomal degradation, blocking the repression of DIAP1 and, thus inhibiting 
cell death. However we cannot discard that the function of the dRYBP-SCFSlmb could be to 
somehow stabilize DIAP1 protein, also known to be regulated by protein ubiquitylation (Holley 
et al., 2002; Ryoo et al., 2002; Yoo et al., 2002), enhancing DIAP1 E3 ubiquitin ligase activity 
promoting Rpr ubiquitylation.  
 
Figure 29. Proposed model for the function of dRYBP and SCF components in the inhibition of 
apoptosis. (A-B) Simplified version of the intrinsic apoptotic pathway. (A) Activation of the apoptotic 
intrinsic pathway requires the pro-apoptotic protein Rpr to repress the anti-apoptotic protein DIAP1. Rpr 
promotes DIAP1 autoubiquitylation, leading to proteasomal degradation {Holley, 2002 #14;Ryoo, 2002 
#15;Yoo, 2002 #16} Consequently, initiator and effector caspases, Dronc and Drice and Dcp-1 respectively, 
are activated to execute cell death. (B) To ensure cell survival the intrinsic apoptotic pathway is inactivated by 
ubiquitylation of Rpr and subsequent proteasomal degradation. We propose that dRYBP together with the 
SCF complex, formed by SKPA, dCUL1 and Slmb, may promote Rpr ubiquitylation. Thus, autoubiquitylation 
of DIAP1 protein is inhibited and, as a result, DIAP1 is capable of inhibiting the activation of initiator and 
effector caspases, thereby, inhibiting cell death and promoting cell survival. 
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Experimental design to validate this model will help us understand the mechanisms of 
inhibition of apoptosis mediated by the novel dRYBP-SCFSlmb complex in Drosophila and 
similar mechanisms likely to function in vertebrate development. Additionally, investigating the 
mechanisms of dRYBP-SCFSlmb complex in Drosophila and in vertebrates may also have an 
impact on the understanding the mechanisms of inhibition of apoptosis in pathological 
development as well. 
 
4. TRANSCRIPTION-DEPENDENT AND TRANSCRIPTION-INDEPENDENT 
FUNCTIONS OF dRYBP 
During this thesis work we have discovered the function of dRYBP in epigenetic regulation 
of gene expression mediated by PcG and trxG proteins and also we have discovered its function 
in apoptosis regulation through its interaction with the SCF E3 ubiquitin ligase. Both of these 
functions depend on a post-translational modification of proteins that consists in ubiquitylation. 
How does dRYBP differentiate between these two functions? We propose that dRYBP is 
ubiquitously expressed therefore it will probably be interacting with PcG and trxG proteins and 
the SCF constitutively. However the balance between interactions may favor one or the other 
direction upon different stimuli. Perhaps under developmental stimuli dRYBP associates more 
with PcG and trxG proteins and upon survival stimuli dRYBP interacts with the SCF to inhibit 
apoptosis. 
Our main findings are that dRYBP biochemically and genetically interacts with the PcG 
(SCE/dRING and dKDM2) and trxG (dBRE1) proteins (Figure 10) and also, that dRYBP 
modulates the levels of post-translational histone modifications (Figures 12 and 14), suggesting 
it is involved in the maintenance of intermediate levels of gene expression by regulating 
transcriptional state of genes (Figure 26). Moreover dRYBP interacts with the SCF E3 ubiquitin 
ligase complex to inhibit apoptosis (Figures 15 and 18) and our findings suggest that this occurs 
through a transcriptional-independent mechanism, particularly through the ubiquitylation and 
consequent proteasomal degradation of a pro-apoptotic protein (Figure 27). Interestingly, recent 
studies are emerging showing that PcG proteins also show transcription-independent functions 
such as the PSC, SCML2 and RING1B proteins. PSC protein is an E3 ubiquitin ligase that 
directly ubiquitylates CYCLINB for proteasomal degradation, a fundamental step for anaphase 
and cytokynesis progression (Mohd-Sarip et al., 2012). Likewise SCML2 (SCM homolog) is 
involved in the formation of the CDK2/CYCLIN/p21 repressor complex, stabilizing p21 and 
controlling cell cycle progression through G1 phase (Lecona et al., 2013). Additionally 
RFN2/RING1B (SCE/dRING homolog) protein directly binds to MDM2 and p53 proteins 
increasing the half-life of MDM2 protein and promoting MDM2-mediated p53 ubiquitylation 
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and consequently leading to p53 degradation by the proteasome, revealing its oncogenic 
function through a transcription-independent function (Wen et al., 2014). These findings reveal 
transcription-independent functions of PcG proteins supporting the transcription-independent 
function of the dRYBP protein through its interaction with the SCF complex.  
The studies in vertebrates and in Drosophila demonstrate that the PcG and trxG proteins 
have an important role in the regulation of proteins other than histones. PcG and trxG are 
proteins that dynamically associate and dissociate from chromatin, for instance, during mitosis 
it is unlikely that these proteins bind to chromatin, thus it is essential to study not only 
transcriptional regulation of target genes but also transcription-independent functions to be able 
to understand normal and pathological development.  
 
  
 
 
 
 
CONCLUSIONS 
 
 
 
CONCLUSIONS 
	   99	  
1. The dRYBP protein coexists, in Drosophila S2 cells, in two different forms: the dRYBP and 
the monoubiquitylated dRYBP (dRYBPub) proteins. Moreover, the dRYBP protein binds to 
ubiquitylated proteins through its N-terminal, where the NZF domain is located. 
2. The dRYBP protein interacts with the H2A, H2B, H2Aub and H2Bub histones in Drosophila 
S2 cells. Additionally, dRYBP genetically interacts with Sce/dRing, dkdm2 and dBre1 and 
biochemically, in Drosophila wild type embryonic nuclear protein extracts (dNE), with 
SCE/dRING, dKDM2 and dBRE1.  
3. The dRYBP protein does not biochemically interact with the PSC, PC, PH and EZ proteins 
and dBRE1 does not interact with the SCE/dRING, dKDM2 and EZ proteins in dNE. 
4. Inactivation of dRYBP decreases levels of monoubiquitylated H2A (H2Aub) and 
monomethylated H3K4 (H3K4me). 
5. dRYBP counteracts dKDM2-mediated H3K36me2	  demethylation and dBRE1-mediated H2B 
monoubiqutylation. These dRYBP-mediated activities may therefore attenuate dkdm2-
mediated repression and dBRE1-mediated activation. 
6. The dRYBP gene interacts genetically with skpA, dCul1 and slmb, all members of the SCF E3 
ubiquitin ligase complex. Moreover, the dRYBP protein biochemically interacts with SKPA 
and dCUL1 proteins. 
7. Inactivation of dRYBP, skpA, dCul1 and slmb induces apoptosis in the wing imaginal disc and 
the inactivation of skpA- and dRYBP-induced apoptosis is dependent on the expression levels 
of the pro-apoptotic gene rpr and the anti-apoptotic protein DIAP1. Thus the dRYBP-SCF 
complex functions by inhibiting the intrinsic apoptotic pathway.  
8. Inactivation of skpA in wing imaginal discs and in Drosophila S2 cells, induces the 
transcriptional activation of rpr and diap1, increases Rpr protein levels and decreases DIAP1 
protein levels.  
9. High levels of SKPA rescues the apoptotic wing phenotype induced by overexpression of 
Rpr. Moreover, in human HEK293 cells, SKPA protein biochemically interacts with Rpr and 
DIAP1 proteins and SKPA overexpression decreases Rpr protein levels, suggesting that the 
dRYBP-SCF complex post-translationally regulates Rpr protein levels. 
10. High levels of SKPA inhibit both the apoptosis that occurs during normal leg development 
and X-ray-induced apoptosis.	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1. INTRODUCCIÓN   
La regulación de la expresión génica es fundamental para el desarrollo normal y 
patológico de los organismos ya que su desregulación puede generar defectos morfológicos y 
enfermedades tales como el cáncer o enfermedades neurodegenerativas. La mosca 
Drosophila melanogaster es un sistema muy útil para el estudio de la regulación de la 
expresión génica, ya que posee unas características biológicas idóneas como son su pequeño 
tamaño, su ciclo de vida corto y su elevada fertilidad. Muy importantemente, las vías de 
señalización que regulan el desarrollo de esta mosca están muy conservadas en la evolución. 
Además, el uso de Drosophila ha promovido la generación de herramientas experimentales 
tanto genéticas como moleculares que no están disponibles en ningún otro sistema modelo, 
haciendo de este organismo un modelo biológico de elección.  
Existen numerosos mecanismos, que tienen lugar a diferentes niveles, implicados en la 
correcta regulación de la expresión génica. La vía de la ubiquitinación está emergiendo como 
un proceso fundamental para la regulación de la expresión génica. El proceso de 
ubiquitinación está filogenéticamente conservado y consiste en la adición covalente de una o 
más moléculas de ubiquitina a la lisina de una proteína diana. Dependiendo de las moléculas 
de ubiquitina unidas y de cómo se unen unas a otras, las consecuencias fisiológicas en la 
proteína diana pueden ser variables. Por ejemplo, la monoubiquitinación de histonas está 
implicada en la regulación de la expresión génica, mientras que la ubiquitinación a través de 
la -K48 es responsable de la degradación vía proteasoma de la proteína diana, un proceso 
esencial para mantener los niveles de proteínas en distintas vías como la apoptosis. En esta 
tesis se han estudiado los mecanismos implicados en la regulación epigenética de la 
expresión génica y en la apoptosis que controlan el desarrollo de Drosophila. 
La regulación epigenética de la expresión génica esta mediada por las proteínas Polycomb 
(PcG) y trithorax (trxG). Estas proteínas se encargan de mantener los estados 
transcripcionales reprimidos y activados respectivamente durante el desarrollo y la vida 
adulta. PcG y trxG son proteínas nucleares asociadas a cromatina que se expresan de forma 
ubicua y que regulan el mantenimiento de la expresión de una gran variedad de genes 
implicados en múltiples procesos biológicos como proliferación, mantenimiento de la 
pluripotencialidad de células madre y tumorogénesis. Existen al menos 40 proteínas PcG y 
trxG descritas por el momento. Los mecanismos de acción de estas proteínas consisten en tres 
pasos. 1) Unión de proteínas PcG o trxG con dominios de unión a ADN, como PHO y Trl, a 
secuencias específicas denominadas Polycomb Response Elements (PREs) y Trithorax 
Response Elements (TREs) en los genes diana. 2) Reclutamiento de proteínas PcG y trxG al 
ADN formando complejos multiméricos. 3) Modificación post-traduccional de histonas, 
como metilación, acetilación y ubiquitinación, generando distintos estados de compactación 
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de la cromatina, resultando en distintos niveles de transcripción. Además existe un tercer 
grupo de genes que codifican para proteínas capaces de interaccionar tanto con proteínas PcG 
y trxG denominados ETP (Enhancers of Trithorax and Polycomb). Entre los ETPs se 
encuentra la proteína dRYBP, objeto de estudio de este trabajo de tesis.  
El gen dRYBP (Ring1B and Yin yang1 Binding Protein) está filogenéticamente 
conservado y codifica para una proteína de 17kDa que se expresa de forma ubicua a lo largo 
del desarrollo. dRYBP contiene en su N-terminal un dominio de unión a ubiquitina (UBD) 
del tipo NZF (Nucleoporin Zinc Finger). La falta de función de dRYBP produce diferentes 
fenotipos que son variables en penetrancia y expresividad, como reducción del tamaño de los 
órganos y esterilidad en hembras, sugiriendo el papel de dRYBP en multitud de procesos 
biológicos. Además, también se sabe que altos niveles de la proteína dRYBP inducen 
apoptosis en la mosca y que su homólogo en vertebrados, RYBP, induce apoptosis en células 
transformadas. Por otro lado, tanto en Drosophila como en vertebrados, se ha descrito la 
interacción de dRYBP/RYBP con diferentes proteínas relacionadas con apoptosis. Sin 
embargo, los mecanismos moleculares a través de los cuales dRYBP/RYBP regulan la 
apoptosis aún se desconocen.  
La apoptosis es un proceso que tiene lugar durante el desarrollo para asegurar la correcta 
morfogénesis del individuo y durante de la vida adulta para eliminar células dañadas. Los 
mecanismos que controlan la apoptosis se encuentran conservados en la evolución y 
consisten, en último término, en la activación de una familia de proteasas, las caspasas, a 
través de señales intrínsecas o extrínsecas. En Drosophila, la vía intrínseca consiste en la 
activación de las proteínas pro-apoptóticas Reaper, Hid y Grim (RHG) (Wing et al., 2001), 
que inhiben a DIAP1 (Drosophila Inhibitor of Apoptosis Protein 1) (Hay et al., 1995). 
Consecuentemente, DIAP1 no puede inhibir a la caspasa iniciadora Dronc, que entonces es 
capaz de activar a las caspasas efectoras Drice y Dcp-1 produciendo la muerte celular (Fuchs 
and Steller, 2011; MacKenzie and Clark, 2012; Steller, 1995). Tanto las proteínas RHG como 
DIAP1 son capaz de ubiquitinarse para ser degradadas por el proteasoma. Por lo tanto, los 
niveles de RHG así como los de DIAP1 deben ser estrictamente regulados para mantener el 
balance entre muerte y supervivencia celular, asegurando así el correcto desarrollo del 
organismo. 
 
2. OBJETIVOS  
Los objetivos de este trabajo de tesis fueron estudiar la funcionalidad de la proteína 
dRYBP en dos procesos en los que la ubiquitinación juega un papel esencial: la regulación 
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epigenética de la expresión génica mediada por las proteínas PcG y trxG y la regulación de la 
apoptosis utilizando Drosophila como sistema modelo.  
Los objetivos específicos de este trabajo de tesis fueron: 
1. Análisis de la función molecular de la proteína dRYBP 
2. Estudio de la función de dRYBP en la regulación epigenética de la expresión génica 
3. Estudio de la función de dRYBP en la regulación de la apoptosis 
 
3. RESULTADOS  
3.1. Análisis de la función molecular de la proteína dRYBP 
Mediante el análisis en células S2 de Drosophila y su posterior detección mediante WB 
hemos descubierto que la proteína dRYBP coexiste en dos formas: dRYBP y dRYBP 
monoubiquitinada (dRYBPub). Además, hemos generado dos construcciones génicas, una, 
con la proteína silvestre y otra, una forma truncada en el que el dominio NZF, que contiene el 
UBD, se encuentra deleccionado. A través de ensayos de “pulldown” con extractos de 
proteínas de células S2 hemos descubierto que el dominio NZF es fundamental para la unión 
de dRYBP a proteínas ubiquitinadas. Además, realizando este mismo tipo de ensayos pero 
usando histonas, hemos descubierto que dRYBP interacciona con las histonas H2A, H2A 
ubiquitinada (H2Aub), H2B y H2B ubiquitinada (H2Bub), confirmando su papel en la 
regulación epigenética de la expresión génica.  
3.2. Estudio de la función de dRYBP en la regulación epigenética de la expresión 
génica 
Ensayos de co-inmunoprecipitación con extractos proteicos nucleares de embriones de 
Drosophila (dNE) muestran que dRYBP interacciona bioquímicamente, por un lado, con las 
proteínas PcG SCE/dRING y dKDM2 y, por otro lado, con la proteína trxG dBRE1. Sin 
embargo dRYBP no interacciona bioquímicamente con las proteínas PcG PSC, PC, PH y EZ. 
Además, a través de la inactivación de dRYBP, Sce/dRing, dkdm2 y dBre1 en Drosophila y el 
análisis fenotípico de los individuos resultantes demuestran que dRYBP interacciona con 
Sce/dRing, con dkdm2 para contrarrestar la represión mediada por dKDM2 y con dBre1 para 
contrarrestar la activación mediada por dBRE1. Para estudiar el papel de dRYBP en la 
regulación epigenética mediada por PcG y trxG inactivamos por un lado, dRYBP, Sce/dRing, 
dkdm2 y dBre1 independientemente y, por otro lado, la inactivación simultánea de dRYBP y 
Sce/dRing, dkdm2 o dBre1 en células S2 posteriormente analizamos mediante WB los niveles 
de modificaciones post-traduccionales de las histonas. Los resultados muestran que dRYBP 
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promueve, de forma directa o indirecta, la ubiquitinación de H2A y la metilación de la H3K4. 
Los resultados también indican que dRYBP es capaz de modular la demetilación de la 
H3K36me2 mediada por dKDM2 y de modular la ubiquitinación de la H2Bub mediada por 
dBRE1. 
3.3. Estudio de la función de dRYBP en la regulación de la apoptosis 
Realizando ensayos de co-inmunoprecipitación con dNE hemos demostrado que dRYBP 
interacciona bioquímicamente con las proteínas SKPA y dCUL1, componentes del complejo 
SCF E3 ubiquitin ligasa. Además la inactivación en el ala simultanea de dRYBP y skpA, 
dCUL1 o slmb muestran que dRYBP interacciona genéticamente con el complejo SCF E3 
ubiquitin ligasa y que este complejo es dRYBP-SCFSlmb es fundamental para la supervivencia 
de la mosca. El análisis de la falta de función de cada uno de los componentes del complejo 
dRYBP-SCFSlmb en el disco imaginal de ala y el posterior análisis mediante 
inmunohistoquímica de la expresión de caspasa-3-activada (C3), muestran que su 
inactivación induce expresión de C3 y, por tanto, revela el papel anti-apoptótico de este 
complejo. El estudio de la expresión de distintos marcadores a través de técnicas 
inmunohistoquímicas en el disco imaginal de ala y del análisis mediante RT-PCR cuantitativa 
en células S2 demuestran la regulación por parte de las proteínas dRYBP y SKPA de la vía 
apoptótica intrínseca. En concreto, la apoptosis inducida por la falta de función de dRYBP y 
skpA es dependiente de los niveles de expresión del gen pro-apoptótico rpr y de la proteína 
anti-apoptótica DIAP1. Además la falta de función de skpA induce expresión transcripcional 
de los genes rpr y diap1, aumenta los niveles de la proteína Rpr y disminuye los niveles de la 
proteína DIAP1. La proteína SKPA interacciona bioquímicamente con Rpr y DIAP1 en 
células S2. Nuestros resultados también indican que la sobre-expresión de SKPA disminuye 
los niveles de expresión de la proteína Rpr en células S2 y también es capaz de rescatar el 
fenotipo apoptótico que se produce en el ala por la sobre-expresión de Rpr. Por último, 
hemos mostrado que la sobre-expresión de SKPA es capaz de inhibir la apoptosis que tiene 
lugar durante el desarrollo y la apoptosis que se produce en respuesta a estrés, confirmando el 
papel anti-apoptótico del complejo dRYBP-SCFSlmb. 
 
4. DISCUSIÓN 
En primer lugar, hemos estudiado la funcionalidad del dominio UBD de la proteína 
dRYBP. Nuestros resultados indican que este dominio es esencial para que dRYBP 
interaccione con proteínas ubiquitinadas, sugiriendo el posible papel de dRYBP como 
proteína adaptadora de ubiquitina. Estos datos concuerdan con los resultados previos en 
vertebrados, en los que muestran que RYBP se une a proteínas ubiquitinadas y ubiquitina a 
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través del NZF. Esta posible función de dRYBP como proteína adaptadora de ubiquitina 
podría explicar la variedad de fenotipos asociados a la falta de función de dRYBP y la 
diversidad de proteínas con las que interacciona.   
También hemos estudiado la función de dRYBP en la regulación epigenética de la 
expresión génica mediada por PcG y trxG, Nuestros resultados indican que dRYBP forma un 
complejo represor junto con las proteínas PcG SCE/dRING y dKDM2 (complejo que hemos 
denominado dRRK) y un complejo activador junto con la proteína dBRE1 (complejo que 
hemos denominado dRB). El análisis de las interacciones genéticas y moleculares entre los 
componentes de estos complejo, al igual que el estudio de las modificaciones post-
traduccionales de las histonas, sugieren que el complejo dRRK lleva a cabo la represión 
génica a través de la ubiquitinación de la H2A. Además, la interacción entre dRYBP y 
dKDM2 contrarresta la demetilación de la H3K36me2 mediada por dKDM2, promoviendo 
niveles intermedios de H3K36me2 y H3K36me, que podría generar un estado transcripcional 
intermedio de represión. Por otro lado, nuestros datos también indican que la interacción 
entre dRYBP y dBRE1 en el complejo dRB contrarresta los niveles de H2Bub mediados por 
dBRE1, sugiriendo la generación de estados transcripcionales intermedios de activación. Por 
tanto, la presencia de dRYBP podría ser fundamental para promover niveles intermedios de 
expresión génica y que podrían estar involucrados en promover la plasticidad epigenética  de 
la regulación mediada por los complejos PcG y trxG durante el desarrollo normal y 
patológico de los individuos 
Por último, el hallazgo de la interacción entre dRYBP y el complejo SCF revela una 
función de dRYBP independiente de la transcripción en la regulación de la apoptosis. 
Nuestros resultados indican que este complejo dRYBP-SCFSlmb tiene un papel esencial en la 
inhibición de la vía apoptótica y además, sugieren un modelo en el que esta inhibición ocurre 
a través de la ubiquitinación de la proteína pro-apoptótica Rpr, para ser degradada por el 
proteasoma. La validación de este modelo y su estudio en vertebrados podría ayudar a 
entender mejor los mecanismos moleculares de la inhibición de la apoptosis en el desarrollo 
normal y de enfermedades 
 
En resumen, el análisis genético y bioquímico en este trabajo de tesis revela el papel de 
dRYBP en la regulación epigenética de la expresión génica y en la regulación de la muerte 
celular. dRYBP controla estos procesos mediante dos mecanismos: uno, dependiente de 
transcripción donde dRYBP, junto con las proteínas PcG y trxG, modula los niveles de 
modificaciones post-traduccionales de histonas. El segundo mecanismo, independiente de la 
transcripción, donde dRYBP regula la apoptosis a través de su interacción con el complejo 
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SCF E3 ubiquitin ligasa, involucrado en la degradación por el proteasoma de proteínas. Este 
papel dual de dRYBP dependiente e independiente de la transcripción concuerda con estudios 
recientes en los que se han visto que otras proteínas del grupo PcG tienen una función 
independiente de las transcripción. Por ejemplo, la proteína PSC ubiquitina a la CiclinaB, 
permitiendo la progresión del ciclo celular (Mohd-Sarip et al., 2012). Por lo tanto, el estudio 
de las proteínas PcG no solo debe centrarse en regulación epigenética si no también en dianas 
independientes de la transcripción para comprender mejor las bases moleculares del 
desarrollo de los organismos.   
RESUMEN EN CASTELLANO 
  121 
5. CONCLUSIONES 
1. La proteína dRYBP coexiste en células S2 de Drosophila en dos formas: dRYBP y 
dRYBP monoubiquitinada (dRYBPub). Además la proteína dRYBP se une a proteínas 
ubiquitinadas a través de su N-terminal, donde se encuentra localizado su dominio NZF. 
2. La proteína dRYBP interacciona con las histonas H2A, H2B, H2Aub and H2Bub en 
células S2 de Drosophila. dRYBP interacciona genéticamente con Sce/dRing, dkdm2 y 
dBre1 y bioquímicamente, en extractos de proteínas nucleares de embriones 
de Drosophila (dNE), con SCE/dRING, dKDM2 y dBRE1.  
3. dRYBP no interacciona bioquímicamente con las proteínas PSC, PC, PH y EZ y dBRE1 
no interacciona con las proteínas SCE/dRING, dKDM2 and EZ en dNE. 
4. La inactivación de dRYBP disminuye los niveles de H2A monoubiquitinada (H2Aub) y de 
H3K4 monometilada (H3K4me). 
5. dRYBP contrarresta la  demetilación de H3K36me2 mediada por dKDM2 y la 
ubiquitinación de H2B ubiquitinada (H2Bub) mediados por dBRE1. Estas actividades de 
dRYBP, por lo tanto, podrían atenuar la represión mediada por dkdm2 y la activación 
mediada por dBre1. 
6. El gen dRYBP interacciona genéticamente con skpA, dCul1 y slmb, componentes del 
complejo SCF E3 ubiquitin ligasa. Además dRYBP interacciona bioquímicamente con las 
proteínas SKPA y dCUL1. 
7. La inactivación de dRYBP, skpA, dCul1 y slmb induce apoptosis en el disco imaginal de 
ala y además la apoptosis producida por la inactivación de skpA y dRYBP es dependiente 
de la expresión del gen pro-apoptótico rpr y de la proteína anti-apoptótica DIAP1. Por lo 
tanto, la función del complejo dRYBP-SCF es inhibir la vía apoptótica intrínseca.  
8.  La inactivación de skpA en el disco imaginal de ala y en células S2 de Drosophila, induce 
la activación transcripcional de rpr y diap1, aumenta los niveles de la proteína Rpr y 
disminuye los niveles de la proteína DIAP1.  
9. Altos niveles de SKPA rescatan el fenotipo apoptótico en el ala inducido por la sobre-
expresión de Rpr. Además, en células humanas HEK293 la proteína SKPA interacciona 
bioquímicamente con las proteínas Rpr y DIAP1 y la sobre-expresión de SKPA reduce los 
niveles de la proteína Rpr, sugiriendo que el complejo dRYBP-SCF modifica post-
traduccionalmente a la proteína Rpr. 
10. Altos niveles de SKPA inhiben la apoptosis que tiene lugar durante el desarrollo de la las 
patas y la apoptosis que tiene lugar en respuesta a rayos-X.  
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APPENDIX 1. dRYBP pulldown assay in wild type S2 cell 
extracts. GST-pulldown assay using wild type S2 cell extracts 
(Input) incubated with GST beads (Mock) or with the fusion 
proteins dRYBP-GST or dRYBPΔNZF-GST. Eluted proteins were 
analyzed by WB using α-Ub antibody. Note the low amount of 
ubiquitylated proteins in wild type S2 cell extracts (Input). 
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APPENDIX 2. Effect of the inactivation of Pall in the wing imaginal disc. (A) Wing 
sdGal4>UAS-PallRNAi. Note the wing does not show any visible phenotype. Scale bar 
represents 0.5mm. (B) Wing disc enGal4>UAS-PallRNAi/UAS-GFP showing GFP (green) 
expression, labeling the engrailed expression domain in the posterior compartment. (B’) 
Wing disc enGal4>UAS-PallRNAi/UAS-GFP showing C3 (red) expression. Note the 
absence of C3 expression in both wing discs compartments. (B’’) Merge of images (B) and 
(B’’). 
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APPENDIX 3. Inactivation of skpA does not induce Ubx expression. (A) Control 
wing disc showing wild type Ubx (green) expression in the peripodial membrane. (A’) 
Control wing disc in (A) showing To-Pro-3 (blue) expression. (A’’) Merge of images 
(A) and (A’). (B) Wing disc sdGal4>UAS-skpARNAi showing Ubx (green) expression. 
Note cells labeled in green correspond to the peripodial membrane and not the proper 
disc. (B’) Control wing disc in (B) showing To-Pro-3 (blue) expression. (B’’) Merge of 
images (B) and (B’). Scale bars represent 100µm. 
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APPENDIX 4. Overexpression of P35 rescues the apoptosis induced by 
inactivation of skpA. (A) Wing disc sdGal4>UAS-skpARNAi/UAS-GFP showing 
activated-Caspase 3 (C3) (red) and To-Pro-3 (blue) expression. (A’) Wing disc 
sdGal4>UAS-skpARNAi/UAS-GFP showing C3 (red) expression. (A’’) Enlargement 
of (A’). (B) Wing disc sdGal4>UAS-skpARNAi/UAS-p35 showing C3 (red) and To-
Pro-3 (blue) expression. (B’) Wing disc sdGal4>UAS-skpARNAi/UAS-p35 showing 
C3 (red) expression. (B’’) Enlargement of image (B’). Note the differential staining 
of the a-C3 antibody due to the detection of inactivated C3, inhibited by 
overexpression of p35 (arrow, detail shown in (B’’)) and due to the detection of 
activated C3, not inhibited by overexpression of p35 (detail shown in (A’’)). Scale 
bars represent 100mm. 
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APPENDIX 5. Inactivation of skpA-mediated apoptosis does not activate p53 
expression and induces JNK activation. (A) Wing disc sdGal4>UAS-p53 showing p53 
(green) expression, as a control for the antibody staining. (B) Wing disc sdGal4>UAS-
skpARNAi/UAS-GFP showing C3 (red) and p53 (green) expression. Note the absence of 
cells expressing p53. (C) Wing disc sdGal4>UAS-skpARNAi/UAS-p53RNAi showing C3 (red) 
expression. Note that the number of apoptotic cells when skpA and p53 are concomitantly 
inactivated is similar to the number of C3 expressing cells when skpA is inactivated 
(compare (C) and (B)). (D) Wing disc puckered-lacZ (puc-lacZ) showing β-GAL (green) 
expression. (E) Wing disc sdGal4>puc-lacZ/UAS-skpARNAi showing β-GAL (green) 
expression. (E’) Wing disc sdGal4>puc-lacZ/UAS-skpARNAi showing β-GAL (green) and 
To-Pro-3 (blue) expression. Scale bars represent 100µm. 
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APPENDIX 6. High levels of dCUL1 and dRYBP proteins 
induce apoptosis. (A) Wing disc sdGal4>UAS-dCUL1 
showing C3 (red) expression. (A’) Wing disc sdGal4>UAS-
dCUL1 showing C3 (red) and To-Pro-3 (blue) expression. (B) 
Wing disc sdGal4>UAS-dRYBP;UAS-GFP showing C3 (red) 
expression. (B’) Wing disc sdGal4>UAS-dRYBP;UAS-GFP 
showing C3 (red) and GFP (green) expression. Scale bars 
represent 100µm. 
 
  
